| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3K4 monomethyltransferase activity | 3.74e-09 | 8 | 187 | 5 | GO:0140945 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 6.77e-09 | 44 | 187 | 8 | GO:0140938 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 1.66e-08 | 10 | 187 | 5 | GO:0140999 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 3.27e-07 | 71 | 187 | 8 | GO:0042054 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | TRERF1 TRADD ABI3 PAXX NACA BCORL1 BCL11A KAT2A SRCAP KMT2E HCN2 RCOR2 NUFIP1 KMT2C NFKBIB TNRC6A TRIM55 PXN MICAL3 BANK1 SHANK1 BIN1 ATN1 DLGAP4 ICE1 SORBS1 DOK2 NCOR2 PPP2R3A KMT2D ABI2 BRD4 SPEN | 3.79e-07 | 1356 | 187 | 33 | GO:0060090 |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 9.44e-07 | 20 | 187 | 5 | GO:0042800 | |
| GeneOntologyMolecularFunction | SH3 domain binding | ABI3 EFS WIPF3 PTPN12 SYNJ1 ARHGAP31 SHANK1 SGIP1 ABI2 INPP5J | 9.93e-07 | 143 | 187 | 10 | GO:0017124 |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TRERF1 TRADD ABI3 NACA BCORL1 BCL11A KAT2A SRCAP KMT2E RCOR2 NUFIP1 KMT2C NFKBIB TNRC6A TRIM55 PXN BANK1 SHANK1 BIN1 ATN1 ICE1 SORBS1 DOK2 NCOR2 PPP2R3A KMT2D ABI2 BRD4 SPEN | 1.25e-06 | 1160 | 187 | 29 | GO:0030674 |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 3.38e-06 | 68 | 187 | 7 | GO:0016279 | |
| GeneOntologyMolecularFunction | signaling adaptor activity | 3.57e-06 | 129 | 187 | 9 | GO:0035591 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 3.73e-06 | 69 | 187 | 7 | GO:0016278 | |
| GeneOntologyMolecularFunction | protein methyltransferase activity | 5.67e-06 | 103 | 187 | 8 | GO:0008276 | |
| GeneOntologyMolecularFunction | protein domain specific binding | TRADD ABI3 EFS WIPF3 HCN2 FOXA3 PCGF6 PTPN12 SYNJ1 ARHGAP31 PKD1 PXN SHANK1 SGIP1 ATN1 DLGAP4 POU2F2 TACC2 SRCIN1 ABI2 TNK2 INPP5J SON | 7.91e-06 | 875 | 187 | 23 | GO:0019904 |
| GeneOntologyMolecularFunction | histone modifying activity | SETD1A SETD1B KAT2A SRCAP KMT2E PRDM2 KMT2C MCM3AP KMT2A SETD2 KMT2D | 1.10e-05 | 229 | 187 | 11 | GO:0140993 |
| GeneOntologyMolecularFunction | actin binding | EPS8 ABI3 WIPF3 FMNL2 WASH6P ANTXR1 MICAL3 BIN1 WASHC1 WHAMM SORBS1 LMOD2 PHACTR4 DAAM2 MYO15A | 4.77e-05 | 479 | 187 | 15 | GO:0003779 |
| GeneOntologyMolecularFunction | N-methyltransferase activity | 5.93e-05 | 105 | 187 | 7 | GO:0008170 | |
| GeneOntologyMolecularFunction | alpha-tubulin binding | 1.24e-04 | 52 | 187 | 5 | GO:0043014 | |
| GeneOntologyMolecularFunction | signaling receptor complex adaptor activity | 1.49e-04 | 54 | 187 | 5 | GO:0030159 | |
| GeneOntologyMolecularFunction | GTPase binding | EPS8 RIN3 FMNL2 GGA3 DOCK5 MAP3K11 BIN1 WHAMM CDC42EP1 MEGF9 ABI2 DAAM2 | 1.55e-04 | 360 | 187 | 12 | GO:0051020 |
| GeneOntologyMolecularFunction | small GTPase binding | EPS8 RIN3 FMNL2 GGA3 DOCK5 MAP3K11 WHAMM CDC42EP1 MEGF9 ABI2 DAAM2 | 2.31e-04 | 321 | 187 | 11 | GO:0031267 |
| GeneOntologyMolecularFunction | apolipoprotein receptor activity | 2.60e-04 | 3 | 187 | 2 | GO:0030226 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | TRERF1 NACA BCORL1 BCL11A KAT2A SRCAP KMT2E RCOR2 KMT2C NFKBIB ATN1 NCOR2 KMT2D BRD4 SPEN | 2.76e-04 | 562 | 187 | 15 | GO:0003712 |
| GeneOntologyMolecularFunction | GTPase activator activity | ARHGAP32 RIN3 ARHGEF11 DOCK5 ASAP2 ARHGAP31 ARAP1 ARHGEF15 TBC1D17 ARAP3 | 3.11e-04 | 279 | 187 | 10 | GO:0005096 |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | ARHGAP32 RIN3 OBSCN ARHGEF11 DOCK5 ASAP2 ARHGAP31 ARAP1 ARHGEF5 ARHGEF15 TBC1D17 ARHGEF40 ARAP3 TNK2 | 3.14e-04 | 507 | 187 | 14 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | ARHGAP32 RIN3 OBSCN ARHGEF11 DOCK5 ASAP2 ARHGAP31 ARAP1 ARHGEF5 ARHGEF15 TBC1D17 ARHGEF40 ARAP3 TNK2 | 3.14e-04 | 507 | 187 | 14 | GO:0030695 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 5.94e-04 | 303 | 187 | 10 | GO:0003713 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity, RNA polymerase II-specific | 9.02e-04 | 320 | 187 | 10 | GO:0001227 | |
| GeneOntologyMolecularFunction | methyltransferase activity | 9.18e-04 | 213 | 187 | 8 | GO:0008168 | |
| GeneOntologyMolecularFunction | DNA-binding transcription repressor activity | 1.04e-03 | 326 | 187 | 10 | GO:0001217 | |
| GeneOntologyMolecularFunction | S-adenosylmethionine-dependent methyltransferase activity | 1.20e-03 | 172 | 187 | 7 | GO:0008757 | |
| GeneOntologyMolecularFunction | transferase activity, transferring one-carbon groups | 1.27e-03 | 224 | 187 | 8 | GO:0016741 | |
| GeneOntologyMolecularFunction | pyruvate dehydrogenase (NAD+) activity | 1.28e-03 | 6 | 187 | 2 | GO:0034604 | |
| GeneOntologyMolecularFunction | pyruvate dehydrogenase [NAD(P)+] activity | 1.28e-03 | 6 | 187 | 2 | GO:0034603 | |
| GeneOntologyMolecularFunction | pyruvate dehydrogenase activity | 1.28e-03 | 6 | 187 | 2 | GO:0004738 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | EPS8 ABI3 WIPF3 OBSCN ZNF207 DYSF FMNL2 WASH6P PXN ANTXR1 MICAL3 BIN1 SGIP1 WASHC1 WHAMM SORBS1 LMOD2 SETD2 PHACTR4 DAAM2 MYO15A | 1.52e-03 | 1099 | 187 | 21 | GO:0008092 |
| GeneOntologyMolecularFunction | protein serine kinase activity | CDK12 SPEG RPS6KB2 OBSCN MAP3K11 WNK2 MAP4K1 TNK2 MAPK7 MAST3 | 2.30e-03 | 363 | 187 | 10 | GO:0106310 |
| GeneOntologyMolecularFunction | phosphatidylinositol 3-kinase inhibitor activity | 2.35e-03 | 8 | 187 | 2 | GO:0141039 | |
| GeneOntologyMolecularFunction | inositol-1,4,5-trisphosphate 5-phosphatase activity | 2.35e-03 | 8 | 187 | 2 | GO:0052658 | |
| GeneOntologyMolecularFunction | structural constituent of presynaptic active zone | 2.35e-03 | 8 | 187 | 2 | GO:0098882 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 2.41e-03 | 60 | 187 | 4 | GO:0034212 | |
| GeneOntologyMolecularFunction | acetyltransferase activity | 2.97e-03 | 104 | 187 | 5 | GO:0016407 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activity | CDK12 SPEG RPS6KB2 OBSCN MAP3K11 WNK2 MAP4K1 BRD4 TNK2 MAPK7 MAST3 | 3.31e-03 | 446 | 187 | 11 | GO:0004674 |
| GeneOntologyMolecularFunction | enzyme regulator activity | CDKN1C ARHGAP32 RIN3 OBSCN ARHGEF11 DOCK5 WASH6P ASAP2 ARHGAP31 PPP1R37 BSN ARAP1 BIN1 ARHGEF5 WASHC1 ARHGEF15 TBC1D17 MMP25 PPP2R3A ARHGEF40 ARAP3 PHACTR4 TNK2 MAPK7 | 3.51e-03 | 1418 | 187 | 24 | GO:0030234 |
| GeneOntologyMolecularFunction | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity | 3.74e-03 | 10 | 187 | 2 | GO:0004439 | |
| GeneOntologyMolecularFunction | RNA polymerase II CTD heptapeptide repeat kinase activity | 3.74e-03 | 10 | 187 | 2 | GO:0008353 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | EPS8 ABI3 WIPF3 OBSCN NAA80 ARHGEF11 NPHP4 FMNL2 WASH6P PCDH15 PXN ANTXR1 MICAL3 ARAP1 SHANK1 BIN1 ARHGEF5 PCLO WASHC1 WHAMM SORBS1 SRCIN1 LMOD2 ARHGEF15 CDC42EP1 MEGF9 ABI2 PHACTR4 LRP1 DAAM2 MYO15A SMTNL2 | 8.49e-13 | 803 | 183 | 32 | GO:0030036 |
| GeneOntologyBiologicalProcess | actin filament-based process | EPS8 ABI3 WIPF3 OBSCN NAA80 ARHGEF11 NPHP4 FMNL2 WASH6P PCDH15 PXN ANTXR1 MICAL3 ARAP1 SHANK1 BIN1 ARHGEF5 PCLO WASHC1 WHAMM SORBS1 SRCIN1 LMOD2 ARHGEF15 CDC42EP1 MEGF9 ABI2 PHACTR4 LRP1 DAAM2 MYO15A SMTNL2 | 2.41e-11 | 912 | 183 | 32 | GO:0030029 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | EPS8 WIPF3 OBSCN ZNF207 NAA80 DYSF WASH6P PCDH15 PXN MICAL3 ARAP1 SHANK1 BIN1 COL12A1 ARHGEF5 WASHC1 WHAMM TACC2 SORBS1 LMOD2 ARHGEF15 CDC42EP1 ADAMTS12 COL18A1 MEGF9 ABI2 DAAM2 SMN1 MYO15A INPP5J | 1.60e-09 | 957 | 183 | 30 | GO:0097435 |
| GeneOntologyBiologicalProcess | actin filament organization | EPS8 WIPF3 NAA80 WASH6P PCDH15 PXN MICAL3 ARAP1 SHANK1 BIN1 ARHGEF5 WASHC1 WHAMM SORBS1 LMOD2 ARHGEF15 CDC42EP1 MEGF9 ABI2 DAAM2 MYO15A | 5.47e-09 | 509 | 183 | 21 | GO:0007015 |
| GeneOntologyBiologicalProcess | regulation of actin filament organization | EPS8 NAA80 WASH6P PXN ARAP1 SHANK1 BIN1 ARHGEF5 WASHC1 WHAMM LMOD2 ARHGEF15 CDC42EP1 MEGF9 ABI2 DAAM2 | 1.17e-08 | 300 | 183 | 16 | GO:0110053 |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | EPS8 NAA80 KAT2A DYSF WASH6P PKD1 PXN ARAP1 SHANK1 BIN1 ARHGEF5 WASHC1 WHAMM LMOD2 ARHGEF15 CDC42EP1 MEGF9 ABI2 LRP1 DAAM2 INPP5J | 5.05e-08 | 579 | 183 | 21 | GO:0051493 |
| GeneOntologyBiologicalProcess | regulation of actin cytoskeleton organization | EPS8 NAA80 WASH6P PXN ARAP1 SHANK1 BIN1 ARHGEF5 WASHC1 WHAMM LMOD2 ARHGEF15 CDC42EP1 MEGF9 ABI2 LRP1 DAAM2 | 6.19e-08 | 384 | 183 | 17 | GO:0032956 |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | EPS8 NAA80 DYSF WASH6P PXN ARAP1 SHANK1 BIN1 ARHGEF5 WASHC1 WHAMM LMOD2 ARHGEF15 CDC42EP1 MEGF9 ABI2 DAAM2 INPP5J | 7.65e-08 | 438 | 183 | 18 | GO:1902903 |
| GeneOntologyBiologicalProcess | regulation of actin filament-based process | EPS8 NAA80 WASH6P PXN ARAP1 SHANK1 BIN1 ARHGEF5 WASHC1 WHAMM LMOD2 ARHGEF15 CDC42EP1 MEGF9 ABI2 LRP1 DAAM2 | 4.00e-07 | 438 | 183 | 17 | GO:0032970 |
| GeneOntologyBiologicalProcess | regulation of cellular component size | BORCS6 EPS8 ARHGAP32 RIN3 NAA80 BCL11A PRR16 WASH6P BIN1 PCLO WASHC1 LMOD2 CDC42EP1 MEGF9 LRP1 DAAM2 | 1.37e-06 | 426 | 183 | 16 | GO:0032535 |
| GeneOntologyBiologicalProcess | actin polymerization or depolymerization | EPS8 NAA80 WASH6P MICAL3 BIN1 WASHC1 LMOD2 CDC42EP1 MEGF9 ABI2 DAAM2 | 4.94e-06 | 222 | 183 | 11 | GO:0008154 |
| GeneOntologyBiologicalProcess | regulation of anatomical structure size | BORCS6 EPS8 ARHGAP32 RIN3 NAA80 BCL11A DOCK5 PRR16 WASH6P PLEKHA7 BIN1 PCLO WASHC1 LMOD2 CDC42EP1 MEGF9 LRP1 DAAM2 | 1.04e-05 | 618 | 183 | 18 | GO:0090066 |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol import | 1.35e-05 | 6 | 183 | 3 | GO:1904109 | |
| GeneOntologyBiologicalProcess | chromatin organization | CDKN1C TET2 SETD1A SETD1B BCORL1 KAT2A SRCAP KMT2E FOXA3 PRDM2 KMT2C PCGF6 MCM3AP NFRKB KMT2A MLLT6 EP400 BICRA BAHD1 SETD2 KMT2D BRD4 | 1.56e-05 | 896 | 183 | 22 | GO:0006325 |
| GeneOntologyBiologicalProcess | actin nucleation | 2.40e-05 | 65 | 183 | 6 | GO:0045010 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | CDKN1C TET2 SETD1A SETD1B BCORL1 KAT2A SRCAP KMT2E FOXA3 PRDM2 KMT2C PCGF6 MCM3AP NFRKB KMT2A MLLT6 EP400 BICRA TAF1C BAHD1 SETD2 KMT2D BRD4 | 2.73e-05 | 999 | 183 | 23 | GO:0071824 |
| GeneOntologyBiologicalProcess | regulation of actin polymerization or depolymerization | 2.98e-05 | 177 | 183 | 9 | GO:0008064 | |
| GeneOntologyBiologicalProcess | regulation of actin filament length | 3.40e-05 | 180 | 183 | 9 | GO:0030832 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | CDKN1C TET2 SETD1A SETD1B KAT2A SRCAP KMT2E PRDM2 KMT2C PCGF6 MCM3AP NFRKB KMT2A EP400 BICRA BAHD1 SETD2 KMT2D BRD4 | 3.44e-05 | 741 | 183 | 19 | GO:0006338 |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | EPS8 ABI3 KAT2A NPHP4 WASH6P NRXN2 PXN ANTXR1 ARAP1 SHANK1 BIN1 CUX2 ARHGEF5 WASHC1 ICE1 SRCIN1 LMOD2 ARHGEF15 TBC1D17 CDC42EP1 MEGF9 ABI2 LRP1 DAAM2 INPP5J | 5.32e-05 | 1189 | 183 | 25 | GO:0044087 |
| GeneOntologyBiologicalProcess | regulation of organelle organization | EPS8 ABI3 ZNF207 NAA80 KAT2A DYSF WASH6P SYNJ1 NFRKB PKD1 PXN ARAP1 SHANK1 BIN1 ARHGEF5 WASHC1 WHAMM LMOD2 ARHGEF15 TBC1D17 CDC42EP1 MEGF9 ABI2 YLPM1 LRP1 DAAM2 INPP5J | 5.53e-05 | 1342 | 183 | 27 | GO:0033043 |
| GeneOntologyBiologicalProcess | regulation of cholesterol import | 5.55e-05 | 9 | 183 | 3 | GO:0060620 | |
| GeneOntologyBiologicalProcess | Arp2/3 complex-mediated actin nucleation | 5.90e-05 | 47 | 183 | 5 | GO:0034314 | |
| GeneOntologyBiologicalProcess | regulation of actin filament polymerization | 7.82e-05 | 156 | 183 | 8 | GO:0030833 | |
| GeneOntologyBiologicalProcess | small GTPase-mediated signal transduction | EPS8 ARHGAP32 OBSCN ARHGEF11 DOCK5 ARHGAP31 ARAP1 ARHGEF5 DOK2 ARHGEF15 CDC42EP1 ARHGEF40 ABI2 PHACTR4 TNK2 | 9.54e-05 | 538 | 183 | 15 | GO:0007264 |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | 2.28e-04 | 231 | 183 | 9 | GO:0032271 | |
| GeneOntologyBiologicalProcess | presynapse to nucleus signaling pathway | 2.33e-04 | 3 | 183 | 2 | GO:0099526 | |
| GeneOntologyBiologicalProcess | cell junction maintenance | 2.79e-04 | 65 | 183 | 5 | GO:0034331 | |
| GeneOntologyBiologicalProcess | actin filament polymerization | 3.03e-04 | 190 | 183 | 8 | GO:0030041 | |
| GeneOntologyBiologicalProcess | cell proliferation in forebrain | 3.50e-04 | 38 | 183 | 4 | GO:0021846 | |
| GeneOntologyBiologicalProcess | snRNA transcription by RNA polymerase II | 3.53e-04 | 16 | 183 | 3 | GO:0042795 | |
| GeneOntologyBiologicalProcess | cholesterol import | 3.53e-04 | 16 | 183 | 3 | GO:0070508 | |
| GeneOntologyBiologicalProcess | positive regulation of supramolecular fiber organization | 3.74e-04 | 196 | 183 | 8 | GO:1902905 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | EPS8 ARHGAP32 ABI3 RAPH1 PDZD7 BCL11A ADAM8 FMNL2 NFIB PCDH15 PXN ARAP1 SHANK1 CUX2 SRCIN1 CDC42EP1 COL18A1 THBS4 ARHGEF40 MEGF9 ABI2 LRP1 SMN1 | 3.84e-04 | 1194 | 183 | 23 | GO:0000902 |
| GeneOntologyBiologicalProcess | positive regulation of sterol transport | 4.27e-04 | 40 | 183 | 4 | GO:0032373 | |
| GeneOntologyBiologicalProcess | positive regulation of cholesterol transport | 4.27e-04 | 40 | 183 | 4 | GO:0032376 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | CDKN1C NACA BCORL1 BCL11A KAT2A PRDM2 PCGF6 NFIB MNT BIN1 CUX2 ATN1 THAP1 NCOR2 MLXIPL ZBTB45 KLF10 MZF1 ZNF746 YLPM1 SPEN | 4.45e-04 | 1053 | 183 | 21 | GO:0000122 |
| GeneOntologyBiologicalProcess | negative regulation of platelet-derived growth factor receptor-beta signaling pathway | 4.64e-04 | 4 | 183 | 2 | GO:2000587 | |
| GeneOntologyBiologicalProcess | presynaptic signal transduction | 4.64e-04 | 4 | 183 | 2 | GO:0098928 | |
| GeneOntologyBiologicalProcess | regulation of actin nucleation | 4.70e-04 | 41 | 183 | 4 | GO:0051125 | |
| GeneOntologyBiologicalProcess | positive regulation of cytoskeleton organization | 5.03e-04 | 205 | 183 | 8 | GO:0051495 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TRERF1 TET2 CDK12 NACA KAT2A FOXA3 PRDM2 NUFIP1 KMT2C NFIB PKD1 KMT2A MLLT6 AKNA POU2F2 MLXIPL KMT2D ELL2 KLF10 PELP1 MZF1 ATOH8 BRD4 ZNF746 MAPK7 | 5.85e-04 | 1390 | 183 | 25 | GO:0045944 |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | TRERF1 CDKN1C NACA BCORL1 BCL11A KAT2A RCOR2 PRDM2 PCGF6 NFIB MNT BIN1 CUX2 ATN1 THAP1 BAHD1 NCOR2 MLXIPL ZBTB45 KLF10 MZF1 ATOH8 ZNF746 YLPM1 SPEN | 6.42e-04 | 1399 | 183 | 25 | GO:0045892 |
| GeneOntologyBiologicalProcess | snRNA transcription | 7.01e-04 | 20 | 183 | 3 | GO:0009301 | |
| GeneOntologyBiologicalProcess | negative regulation of RNA biosynthetic process | TRERF1 CDKN1C NACA BCORL1 BCL11A KAT2A RCOR2 PRDM2 PCGF6 NFIB MNT BIN1 CUX2 ATN1 THAP1 BAHD1 NCOR2 MLXIPL ZBTB45 KLF10 MZF1 ATOH8 ZNF746 YLPM1 SPEN | 7.41e-04 | 1413 | 183 | 25 | GO:1902679 |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 7.69e-04 | 5 | 183 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | presynaptic active zone assembly | 7.69e-04 | 5 | 183 | 2 | GO:1904071 | |
| GeneOntologyBiologicalProcess | dendritic spine morphogenesis | 7.73e-04 | 81 | 183 | 5 | GO:0060997 | |
| GeneOntologyBiologicalProcess | dendritic cell antigen processing and presentation | 8.12e-04 | 21 | 183 | 3 | GO:0002468 | |
| GeneOntologyBiologicalProcess | protein polymerization | EPS8 ZNF207 WASH6P BIN1 WASHC1 LMOD2 CDC42EP1 MEGF9 DAAM2 INPP5J | 8.30e-04 | 334 | 183 | 10 | GO:0051258 |
| GeneOntologyCellularComponent | lamellipodium | ABI3 RAPH1 FAM89B DYSF WASH6P ARHGAP31 PXN ANTXR1 WASHC1 SRCIN1 ARAP3 ABI2 PHACTR4 | 1.97e-07 | 230 | 190 | 13 | GO:0030027 |
| GeneOntologyCellularComponent | nuclear body | SETD1A SETD1B RAPH1 CDK12 ZC3H13 OBSCN BCL11A SRCAP KMT2E NPHP4 TREML1 CASC3 AFF2 EP400 ICE1 CHAMP1 THAP1 NCOR2 SLC2A4RG ATOH8 YLPM1 SMN1 INAVA MAPK7 DNAAF1 SON | 1.99e-07 | 903 | 190 | 26 | GO:0016604 |
| GeneOntologyCellularComponent | cell leading edge | EPS8 ABI3 RAPH1 FAM89B HCN2 DYSF ABCA7 WASH6P ARHGAP31 PXN ANTXR1 ATN1 WASHC1 SRCIN1 ARAP3 ABI2 PHACTR4 INPP5J | 7.74e-07 | 500 | 190 | 18 | GO:0031252 |
| GeneOntologyCellularComponent | nuclear protein-containing complex | TRERF1 SETD1A SETD1B CDK12 PAXX BCL11A KAT2A SRCAP KMT2E RCOR2 NUFIP1 KMT2C PCGF6 MCM3AP NFRKB KMT2A CASC3 BIN1 AFF2 EP400 BICRA TAF1C ICE1 NUP214 BAHD1 NCOR2 MLXIPL KMT2D ELL2 PELP1 BRD4 | 2.52e-06 | 1377 | 190 | 31 | GO:0140513 |
| GeneOntologyCellularComponent | transcription elongation factor complex | 1.16e-05 | 56 | 190 | 6 | GO:0008023 | |
| GeneOntologyCellularComponent | nuclear speck | SETD1A SETD1B CDK12 ZC3H13 KMT2E TREML1 CASC3 AFF2 EP400 SLC2A4RG ATOH8 YLPM1 DNAAF1 SON | 4.24e-05 | 431 | 190 | 14 | GO:0016607 |
| GeneOntologyCellularComponent | actin-based cell projection | EPS8 ABI3 RAPH1 PDZD7 WASH6P PCDH15 ANTXR1 WASHC1 SRCIN1 ABI2 MYO15A | 5.02e-05 | 278 | 190 | 11 | GO:0098858 |
| GeneOntologyCellularComponent | methyltransferase complex | 5.90e-05 | 108 | 190 | 7 | GO:0034708 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 6.23e-05 | 75 | 190 | 6 | GO:0035097 | |
| GeneOntologyCellularComponent | histone deacetylase complex | 1.26e-04 | 85 | 190 | 6 | GO:0000118 | |
| GeneOntologyCellularComponent | actin cytoskeleton | ARHGAP32 FOXA3 ADAM8 DOCK5 PTPN12 PXN NEURL1B BIN1 ARHGEF5 SORBS1 SRCIN1 LMOD2 ABI2 MYO15A SMTNL2 | 2.62e-04 | 576 | 190 | 15 | GO:0015629 |
| GeneOntologyCellularComponent | WASH complex | 3.10e-04 | 15 | 190 | 3 | GO:0071203 | |
| GeneOntologyCellularComponent | podosome | 5.15e-04 | 41 | 190 | 4 | GO:0002102 | |
| GeneOntologyCellularComponent | alpha-ketoacid dehydrogenase complex | 5.45e-04 | 18 | 190 | 3 | GO:0045240 | |
| GeneOntologyCellularComponent | fibrillar center | 5.72e-04 | 156 | 190 | 7 | GO:0001650 | |
| GeneOntologyCellularComponent | filopodium | 9.18e-04 | 123 | 190 | 6 | GO:0030175 | |
| GeneOntologyCellularComponent | chromatin | SETD1A BCL11A KAT2A SRCAP KMT2E FOXA3 RCOR2 NUFIP1 NFIB NFRKB MNT CUX2 EP400 BICRA TLX3 POU2F2 ICE1 THAP1 NCOR2 MLXIPL KLF10 PELP1 ATOH8 BRD4 ZFHX2 LYL1 | 9.29e-04 | 1480 | 190 | 26 | GO:0000785 |
| GeneOntologyCellularComponent | SWI/SNF superfamily-type complex | 1.84e-03 | 96 | 190 | 5 | GO:0070603 | |
| GeneOntologyCellularComponent | INO80-type complex | 2.05e-03 | 28 | 190 | 3 | GO:0097346 | |
| GeneOntologyCellularComponent | zonula adherens | 2.22e-03 | 8 | 190 | 2 | GO:0005915 | |
| GeneOntologyCellularComponent | pyruvate dehydrogenase complex | 2.22e-03 | 8 | 190 | 2 | GO:0045254 | |
| GeneOntologyCellularComponent | cytoskeleton of presynaptic active zone | 2.22e-03 | 8 | 190 | 2 | GO:0048788 | |
| GeneOntologyCellularComponent | cyclin/CDK positive transcription elongation factor complex | 2.84e-03 | 9 | 190 | 2 | GO:0008024 | |
| GeneOntologyCellularComponent | cerebellar mossy fiber | 2.84e-03 | 9 | 190 | 2 | GO:0044300 | |
| Domain | SH3 | EPS8 ARHGAP32 ABI3 EFS OBSCN DOCK5 ASAP2 MAP3K11 SHANK1 BIN1 ARHGEF5 SORBS1 ABI2 TNK2 MYO15A | 4.19e-09 | 216 | 185 | 15 | SM00326 |
| Domain | SH3 | EPS8 ARHGAP32 ABI3 EFS OBSCN DOCK5 ASAP2 MAP3K11 SHANK1 BIN1 ARHGEF5 SORBS1 ABI2 TNK2 MYO15A | 4.19e-09 | 216 | 185 | 15 | PS50002 |
| Domain | SH3_9 | ARHGAP32 ABI3 EFS ASAP2 MAP3K11 BIN1 ARHGEF5 SORBS1 ABI2 TNK2 | 5.01e-09 | 78 | 185 | 10 | PF14604 |
| Domain | SH3_domain | EPS8 ARHGAP32 ABI3 EFS OBSCN DOCK5 ASAP2 MAP3K11 SHANK1 BIN1 ARHGEF5 SORBS1 ABI2 TNK2 MYO15A | 5.37e-09 | 220 | 185 | 15 | IPR001452 |
| Domain | SET | 5.75e-09 | 41 | 185 | 8 | PF00856 | |
| Domain | Post-SET_dom | 6.42e-09 | 16 | 185 | 6 | IPR003616 | |
| Domain | PostSET | 6.42e-09 | 16 | 185 | 6 | SM00508 | |
| Domain | POST_SET | 6.42e-09 | 16 | 185 | 6 | PS50868 | |
| Domain | SET | 1.51e-08 | 46 | 185 | 8 | SM00317 | |
| Domain | SET_dom | 3.00e-08 | 50 | 185 | 8 | IPR001214 | |
| Domain | SET | 3.00e-08 | 50 | 185 | 8 | PS50280 | |
| Domain | SH3_1 | EPS8 ARHGAP32 ABI3 EFS DOCK5 ASAP2 MAP3K11 BIN1 ARHGEF5 SORBS1 ABI2 TNK2 | 8.82e-08 | 164 | 185 | 12 | PF00018 |
| Domain | WH2 | 3.30e-06 | 24 | 185 | 5 | PS51082 | |
| Domain | FYrich_C | 9.42e-06 | 5 | 185 | 3 | IPR003889 | |
| Domain | FYrich_N | 9.42e-06 | 5 | 185 | 3 | IPR003888 | |
| Domain | FYRC | 9.42e-06 | 5 | 185 | 3 | SM00542 | |
| Domain | FYRN | 9.42e-06 | 5 | 185 | 3 | SM00541 | |
| Domain | FYRN | 9.42e-06 | 5 | 185 | 3 | PF05964 | |
| Domain | FYRC | 9.42e-06 | 5 | 185 | 3 | PF05965 | |
| Domain | FYRC | 9.42e-06 | 5 | 185 | 3 | PS51543 | |
| Domain | FYRN | 9.42e-06 | 5 | 185 | 3 | PS51542 | |
| Domain | MYB_LIKE | 3.48e-05 | 38 | 185 | 5 | PS50090 | |
| Domain | WH2_dom | 4.89e-05 | 21 | 185 | 4 | IPR003124 | |
| Domain | EPHD | 5.93e-05 | 22 | 185 | 4 | PS51805 | |
| Domain | N-SET | 9.76e-05 | 2 | 185 | 2 | PF11764 | |
| Domain | Paxillin | 9.76e-05 | 2 | 185 | 2 | IPR001904 | |
| Domain | N-SET | 9.76e-05 | 2 | 185 | 2 | SM01291 | |
| Domain | COMPASS_Set1_N-SET | 9.76e-05 | 2 | 185 | 2 | IPR024657 | |
| Domain | Znf_piccolo | 9.76e-05 | 2 | 185 | 2 | IPR008899 | |
| Domain | zf-piccolo | 9.76e-05 | 2 | 185 | 2 | PF05715 | |
| Domain | ABI | 9.76e-05 | 2 | 185 | 2 | IPR028457 | |
| Domain | PH_DOMAIN | EPS8 RAPH1 OBSCN ARHGEF11 ASAP2 PLEKHA7 ARAP1 ARHGEF5 DOK2 ARHGEF40 ARAP3 | 1.10e-04 | 279 | 185 | 11 | PS50003 |
| Domain | PH_domain | EPS8 RAPH1 OBSCN ARHGEF11 ASAP2 PLEKHA7 ARAP1 ARHGEF5 DOK2 ARHGEF40 ARAP3 | 1.14e-04 | 280 | 185 | 11 | IPR001849 |
| Domain | SANT | 1.33e-04 | 50 | 185 | 5 | SM00717 | |
| Domain | SANT/Myb | 1.61e-04 | 52 | 185 | 5 | IPR001005 | |
| Domain | SH3_2 | 2.12e-04 | 86 | 185 | 6 | PF07653 | |
| Domain | SH3_2 | 2.12e-04 | 86 | 185 | 6 | IPR011511 | |
| Domain | E3_binding | 2.91e-04 | 3 | 185 | 2 | PF02817 | |
| Domain | E3-bd | 2.91e-04 | 3 | 185 | 2 | IPR004167 | |
| Domain | Abi_HHR | 2.91e-04 | 3 | 185 | 2 | PF07815 | |
| Domain | - | 2.91e-04 | 3 | 185 | 2 | 4.10.320.10 | |
| Domain | Abl-interactor_HHR_dom | 2.91e-04 | 3 | 185 | 2 | IPR012849 | |
| Domain | Anthrax_toxin_rcpt_extracel | 2.91e-04 | 3 | 185 | 2 | IPR008400 | |
| Domain | Anth_Ig | 2.91e-04 | 3 | 185 | 2 | PF05587 | |
| Domain | PH_dom-like | EPS8 RAPH1 OBSCN ARHGEF11 ASAP2 PLEKHA7 ARAP1 ARHGEF5 TNS2 DOK2 ARHGEF15 ARHGEF40 ARAP3 | 3.37e-04 | 426 | 185 | 13 | IPR011993 |
| Domain | Myb_DNA-binding | 3.84e-04 | 35 | 185 | 4 | PF00249 | |
| Domain | DH_1 | 3.99e-04 | 63 | 185 | 5 | PS00741 | |
| Domain | PH | RAPH1 OBSCN ARHGEF11 ASAP2 PLEKHA7 ARAP1 ARHGEF5 DOK2 ARHGEF40 ARAP3 | 4.68e-04 | 278 | 185 | 10 | SM00233 |
| Domain | RA | 4.77e-04 | 37 | 185 | 4 | PS50200 | |
| Domain | - | EPS8 RAPH1 OBSCN ARHGEF11 ASAP2 PLEKHA7 ARAP1 ARHGEF5 TNS2 DOK2 ARHGEF40 ARAP3 | 5.42e-04 | 391 | 185 | 12 | 2.30.29.30 |
| Domain | CAT-like_dom | 5.78e-04 | 4 | 185 | 2 | IPR023213 | |
| Domain | HSA | 5.78e-04 | 4 | 185 | 2 | SM00573 | |
| Domain | 2-oxoacid_dh | 5.78e-04 | 4 | 185 | 2 | PF00198 | |
| Domain | 2-oxoacid_DH_actylTfrase | 5.78e-04 | 4 | 185 | 2 | IPR001078 | |
| Domain | HSA | 5.78e-04 | 4 | 185 | 2 | PS51204 | |
| Domain | - | 5.78e-04 | 4 | 185 | 2 | 3.30.559.10 | |
| Domain | HSA_dom | 5.78e-04 | 4 | 185 | 2 | IPR014012 | |
| Domain | HSA | 5.78e-04 | 4 | 185 | 2 | PF07529 | |
| Domain | GDS_CDC24_CS | 5.85e-04 | 39 | 185 | 4 | IPR001331 | |
| Domain | RA_dom | 6.45e-04 | 40 | 185 | 4 | IPR000159 | |
| Domain | RhoGEF | 6.49e-04 | 70 | 185 | 5 | PF00621 | |
| Domain | DH_2 | 6.49e-04 | 70 | 185 | 5 | PS50010 | |
| Domain | Znf_FYVE_PHD | 6.63e-04 | 147 | 185 | 7 | IPR011011 | |
| Domain | - | 6.93e-04 | 71 | 185 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 6.93e-04 | 71 | 185 | 5 | IPR000219 | |
| Domain | PHD | 8.90e-04 | 75 | 185 | 5 | PF00628 | |
| Domain | NEUZ | 9.57e-04 | 5 | 185 | 2 | SM00588 | |
| Domain | NHR | 9.57e-04 | 5 | 185 | 2 | PS51065 | |
| Domain | NHR_dom | 9.57e-04 | 5 | 185 | 2 | IPR006573 | |
| Domain | 2-oxoA_DH_lipoyl-BS | 9.57e-04 | 5 | 185 | 2 | IPR003016 | |
| Domain | Neuralized | 9.57e-04 | 5 | 185 | 2 | PF07177 | |
| Domain | LIPOYL | 9.57e-04 | 5 | 185 | 2 | PS00189 | |
| Domain | CRIB_dom | 1.12e-03 | 21 | 185 | 3 | IPR000095 | |
| Domain | Znf_PHD-finger | 1.13e-03 | 79 | 185 | 5 | IPR019787 | |
| Domain | Myb-like_dom | 1.43e-03 | 6 | 185 | 2 | IPR017877 | |
| Domain | TSPN | 1.46e-03 | 23 | 185 | 3 | SM00210 | |
| Domain | - | RC3H1 KMT2E RNF214 KMT2C PCGF6 TRIM55 KMT2A MLLT6 NEURL1B BSN PCLO KMT2D | 1.78e-03 | 449 | 185 | 12 | 3.30.40.10 |
| Domain | PHD | 1.92e-03 | 89 | 185 | 5 | SM00249 | |
| Domain | PH | 2.06e-03 | 229 | 185 | 8 | PF00169 | |
| Domain | SANT_dom | 2.10e-03 | 26 | 185 | 3 | IPR017884 | |
| Domain | Znf_PHD | 2.11e-03 | 91 | 185 | 5 | IPR001965 | |
| Domain | Znf_RING/FYVE/PHD | RC3H1 KMT2E RNF214 KMT2C PCGF6 TRIM55 KMT2A MLLT6 NEURL1B BSN PCLO KMT2D | 2.13e-03 | 459 | 185 | 12 | IPR013083 |
| Domain | AT_hook | 2.35e-03 | 27 | 185 | 3 | SM00384 | |
| Domain | AT_hook_DNA-bd_motif | 2.35e-03 | 27 | 185 | 3 | IPR017956 | |
| Domain | ZF_PHD_2 | 2.55e-03 | 95 | 185 | 5 | PS50016 | |
| Domain | Laminin_G | 2.61e-03 | 58 | 185 | 4 | IPR001791 | |
| Domain | SANT | 2.61e-03 | 28 | 185 | 3 | PS51293 | |
| Domain | DAD_dom | 2.63e-03 | 8 | 185 | 2 | IPR014767 | |
| Domain | PTB | 2.63e-03 | 8 | 185 | 2 | IPR013625 | |
| Domain | DAD | 2.63e-03 | 8 | 185 | 2 | PS51231 | |
| Domain | PTB | 2.63e-03 | 8 | 185 | 2 | PF08416 | |
| Domain | ZF_PHD_1 | 2.67e-03 | 96 | 185 | 5 | PS01359 | |
| Domain | ArfGap | 2.89e-03 | 29 | 185 | 3 | SM00105 | |
| Domain | ARFGAP | 2.89e-03 | 29 | 185 | 3 | PS50115 | |
| Domain | ArfGap | 2.89e-03 | 29 | 185 | 3 | PF01412 | |
| Domain | ArfGAP | 2.89e-03 | 29 | 185 | 3 | IPR001164 | |
| Domain | RhoGAP | 3.32e-03 | 62 | 185 | 4 | SM00324 | |
| Domain | Drf_GBD | 3.36e-03 | 9 | 185 | 2 | PF06371 | |
| Domain | Drf_FH3 | 3.36e-03 | 9 | 185 | 2 | PF06367 | |
| Domain | FH3_dom | 3.36e-03 | 9 | 185 | 2 | IPR010472 | |
| Pathway | WP_HISTONE_MODIFICATIONS | 1.63e-07 | 65 | 133 | 8 | M39374 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | ARHGAP32 WIPF3 ARHGEF11 FMNL2 ARHGAP31 MAP3K11 ARAP1 ARHGEF5 ARHGEF15 CDC42EP1 ARAP3 | 2.37e-07 | 155 | 133 | 11 | M41808 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGAP32 WIPF3 OBSCN ARHGEF11 FMNL2 DOCK5 ARHGAP31 MAP3K11 ARAP1 ARHGEF5 WHAMM ARHGEF15 CDC42EP1 ARHGEF40 ARAP3 ABI2 SPEN | 1.12e-06 | 450 | 133 | 17 | M27078 |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | ARHGAP32 WIPF3 ARHGEF11 DOCK5 ARHGAP31 ARAP1 ARHGEF5 ARHGEF15 CDC42EP1 ARAP3 ABI2 | 1.32e-06 | 184 | 133 | 11 | M41809 |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 2.50e-06 | 42 | 133 | 6 | M48018 | |
| Pathway | PID_RHOA_REG_PATHWAY | 4.33e-06 | 46 | 133 | 6 | M68 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | ARHGAP32 ARHGEF11 DOCK5 ARHGAP31 ARAP1 ARHGEF5 ARHGEF15 CDC42EP1 ARAP3 ABI2 | 6.08e-06 | 175 | 133 | 10 | MM15599 |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | ARHGAP32 OBSCN ARHGEF11 ARHGAP31 ARAP1 ARHGEF5 ARHGEF15 ARHGEF40 ARAP3 | 1.16e-05 | 149 | 133 | 9 | M41805 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGAP32 OBSCN ARHGEF11 FMNL2 DOCK5 ARHGAP31 MAP3K11 ARAP1 ARHGEF5 WHAMM ARHGEF15 CDC42EP1 ARAP3 ABI2 SPEN | 1.67e-05 | 439 | 133 | 15 | MM15595 |
| Pathway | REACTOME_FORMATION_OF_WDR5_CONTAINING_HISTONE_MODIFYING_COMPLEXES | 2.71e-05 | 38 | 133 | 5 | MM17073 | |
| Pathway | REACTOME_CDC42_GTPASE_CYCLE | 2.94e-05 | 94 | 133 | 7 | MM15598 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 5.03e-05 | 70 | 133 | 6 | M27231 | |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | ARHGAP32 OBSCN ARHGEF11 ARHGAP31 ARAP1 ARHGEF5 ARHGEF15 ARAP3 | 5.91e-05 | 142 | 133 | 8 | MM15576 |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 6.97e-05 | 46 | 133 | 5 | MM14933 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 2.31e-04 | 59 | 133 | 5 | M11215 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 2.91e-04 | 96 | 133 | 6 | M27792 | |
| Pathway | WP_PATHWAYS_AFFECTED_IN_ADENOID_CYSTIC_CARCINOMA | 3.64e-04 | 65 | 133 | 5 | M39682 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGAP32 WIPF3 OBSCN ARHGEF11 FMNL2 DOCK5 ARHGAP31 MAP3K11 ARAP1 ARHGEF5 WHAMM ARHGEF15 CDC42EP1 ARAP3 ABI2 SPEN | 4.02e-04 | 649 | 133 | 16 | MM15690 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGAP32 WIPF3 OBSCN ARHGEF11 FMNL2 DOCK5 ARHGAP31 MAP3K11 ARAP1 ARHGEF5 WHAMM ARHGEF15 CDC42EP1 ARHGEF40 ARAP3 ABI2 SPEN | 4.32e-04 | 720 | 133 | 17 | M41838 |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 5.48e-04 | 71 | 133 | 5 | MM15604 | |
| Pathway | REACTOME_RHOC_GTPASE_CYCLE | 6.63e-04 | 74 | 133 | 5 | M41807 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 6.63e-04 | 74 | 133 | 5 | M41814 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 7.49e-04 | 76 | 133 | 5 | MM1433 | |
| Pathway | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | 7.49e-04 | 76 | 133 | 5 | M19832 | |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 7.67e-04 | 44 | 133 | 4 | MM15527 | |
| Pathway | REACTOME_SENSORY_PROCESSING_OF_SOUND | 7.95e-04 | 77 | 133 | 5 | M41822 | |
| Pathway | WP_EGFEGFR_SIGNALING | 8.62e-04 | 162 | 133 | 7 | M39334 | |
| Pathway | REACTOME_G_ALPHA_12_13_SIGNALLING_EVENTS | 9.46e-04 | 80 | 133 | 5 | M800 | |
| Pathway | BIOCARTA_MAPK_PATHWAY | 1.00e-03 | 81 | 133 | 5 | M13863 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.10e-03 | 272 | 133 | 9 | M29619 | |
| Pathway | REACTOME_PDH_COMPLEX_SYNTHESIZES_ACETYL_COA_FROM_PYR | 1.29e-03 | 6 | 133 | 2 | M48273 | |
| Pathway | REACTOME_PDH_COMPLEX_SYNTHESIZES_ACETYL_COA_FROM_PYR | 1.29e-03 | 6 | 133 | 2 | MM17245 | |
| Pathway | REACTOME_NRAGE_SIGNALS_DEATH_THROUGH_JNK | 1.44e-03 | 52 | 133 | 4 | MM14743 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SETD1A RIN3 SETD1B CDK12 SPEG OBSCN KAT2A SRCAP ARHGEF11 DYSF NPHP4 ABCA7 GGA3 KMT2C TULP4 SYNJ1 MCM3AP A4GALT PKD1 PXN NAV1 MAP3K11 MLLT6 MICAL3 WNK2 ARAP1 EP400 BICRA UBR4 AKNA ICE1 NUP214 BAHD1 TBC1D17 ANO8 RABL6 NCOR2 ARHGEF40 KMT2D ARAP3 SLC2A4RG KLF10 BRD4 TNK2 SLC45A1 SNAPC4 SPEN | 5.21e-28 | 1105 | 194 | 47 | 35748872 |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | TRERF1 SETD1A ARHGAP32 KMT2E GGA3 DOCK5 ASAP2 TULP4 ARHGAP31 MLLT6 BSN PLEKHA7 WNK2 ARAP1 CUX2 AFF2 ATN1 EP400 BICRA ARHGEF5 UBR4 NUP214 NCOR2 MAP4K1 YLPM1 TNK2 INAVA SPEN NEURL4 SON | 5.06e-24 | 430 | 194 | 30 | 35044719 |
| Pubmed | Interaction network of human early embryonic transcription factors. | TRERF1 TET2 SETD1A BCORL1 BCL11A PRDM2 KMT2C PCGF6 NFIB MCM3AP NFRKB KMT2A ATN1 EP400 BICRA ZBTB9 NUP214 NCOR2 KMT2D ZNF746 SPEN | 9.66e-16 | 351 | 194 | 21 | 38297188 |
| Pubmed | TRERF1 TET2 SETD1A ARHGAP32 RC3H1 NACA BCORL1 BCL11A GIGYF1 KAT2A SRCAP PRDM2 RNF214 KMT2C PCGF6 NFIB NFKBIB NFRKB TNRC6A KMT2A DLAT MLLT6 MNT ATN1 EP400 BICRA UBR4 TLX3 ZBTB9 NUP214 NCOR2 KMT2D KLF10 ZNF746 YLPM1 SMN1 SPEN | 5.18e-15 | 1429 | 194 | 37 | 35140242 | |
| Pubmed | Skirting the pitfalls: a clear-cut nomenclature for H3K4 methyltransferases. | 7.73e-13 | 8 | 194 | 6 | 23130995 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TRERF1 RAPH1 CDK12 ZC3H13 PRDM2 NFRKB KMT2A MICAL3 BIN1 ATN1 EP400 FNBP4 NUP214 CHAMP1 NCOR2 SETD2 KMT2D MAP4K1 BRD4 PHACTR4 YLPM1 PROSER2 SNAPC4 SPEN SON | 1.93e-12 | 774 | 194 | 25 | 15302935 |
| Pubmed | TRERF1 TET2 RAPH1 BCORL1 RCOR2 PRDM2 SYNJ1 TNRC6A PXN NAV1 UBR4 ZBTB9 ICE1 NUP214 CHAMP1 NCOR2 KMT2D BRD4 LRP1 | 3.12e-12 | 418 | 194 | 19 | 34709266 | |
| Pubmed | TET2 ARHGAP32 ARHGEF11 ASAP2 NRXN2 MCM3AP NAV1 EP400 FNBP4 SORBS1 BAHD1 MAST3 | 1.05e-11 | 130 | 194 | 12 | 12421765 | |
| Pubmed | 3.10e-11 | 57 | 194 | 9 | 18022353 | ||
| Pubmed | ARHGAP32 ARHGEF11 FMNL2 KMT2C ASAP2 ARHGAP31 MCM3AP TNRC6A NAV1 MAP3K11 WNK2 SHANK1 BICRA SORBS1 NUP214 CDC42EP1 TNK2 WASH2P MAPK7 | 4.17e-11 | 486 | 194 | 19 | 20936779 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | BORCS6 GIGYF1 NPHP4 ARHGAP31 MCM3AP NFRKB TNRC6A NAV1 NCOR2 KMT2D ZNF746 LRP1 SPEN | 4.23e-11 | 184 | 194 | 13 | 32908313 |
| Pubmed | BCL11A GIGYF1 KAT2A SRCAP FMNL2 ABCA7 RCOR2 NUFIP1 MCM3AP NFRKB TNRC6A DLAT ATN1 EP400 BICRA TAF1C ZBTB9 CHAMP1 PDHX CDC42EP1 NCOR2 SETD2 ZNF526 ARHGEF40 BRD4 LRP1 SON | 1.68e-10 | 1116 | 194 | 27 | 31753913 | |
| Pubmed | TET2 SETD1A CDK12 NACA GGA3 KMT2C NRXN2 ARHGAP31 TNRC6A BSN WNK2 ARAP1 EP400 FNBP4 AKNA ICE1 SRCIN1 CHAMP1 BAHD1 | 1.75e-10 | 529 | 194 | 19 | 14621295 | |
| Pubmed | 2.83e-10 | 8 | 194 | 5 | 22266653 | ||
| Pubmed | RIN3 EFS HCN2 ARHGEF11 ASAP2 TULP4 PKD1 WNK2 BIN1 AFF2 BICRA DLGAP4 MAP4K1 BRD4 SPEN | 6.28e-10 | 329 | 194 | 15 | 17474147 | |
| Pubmed | 6.35e-10 | 9 | 194 | 5 | 22665483 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | ZC3H13 BCORL1 KAT2A SRCAP PRDM2 DOCK5 KMT2C PCGF6 NFIB NFRKB KMT2A MNT EP400 TAF1C TLX3 FNBP4 NUP214 CHAMP1 THAP1 NCOR2 MLXIPL SETD2 KMT2D PELP1 BRD4 YLPM1 SPEN SON | 9.17e-10 | 1294 | 194 | 28 | 30804502 |
| Pubmed | TRERF1 ARHGAP32 BCL11A HCN2 ARHGEF11 RCOR2 SYNJ1 NAV1 BSN WNK2 SHANK1 CASC3 BIN1 SGIP1 PRR36 DLGAP4 UBR4 SORBS1 NCOR2 PELP1 ABI2 YLPM1 LRP1 NEURL4 | 1.06e-09 | 963 | 194 | 24 | 28671696 | |
| Pubmed | Structural basis for activity regulation of MLL family methyltransferases. | 1.93e-09 | 22 | 194 | 6 | 26886794 | |
| Pubmed | SETD1A RAPH1 CDK12 SRCAP GGA3 KMT2C SYNJ1 NFRKB KMT2A EP400 FNBP4 CHAMP1 SETD2 KMT2D BRD4 PHACTR4 YLPM1 SPEN | 2.27e-09 | 549 | 194 | 18 | 38280479 | |
| Pubmed | 3.93e-09 | 12 | 194 | 5 | 27563068 | ||
| Pubmed | SETD1B SPEG BCL11A GGA3 MCM3AP NAV1 MICAL3 EP400 DLGAP4 SORBS1 NUP214 MEGF9 DAAM2 SPEN SON | 1.11e-08 | 407 | 194 | 15 | 12693553 | |
| Pubmed | EPS8 ARHGAP32 BCL11A ARHGEF11 FMNL2 NRXN2 SYNJ1 NAV1 KMT2A DLAT MICAL3 BSN PLEKHA7 VARS1 WNK2 SHANK1 BIN1 SGIP1 PRR36 PCLO DLGAP4 SORBS1 SRCIN1 PDHX MLXIPL THBS4 FBXL16 | 3.31e-08 | 1431 | 194 | 27 | 37142655 | |
| Pubmed | TRERF1 TET2 NFIB NFRKB KMT2A ATN1 EP400 ZBTB9 CHAMP1 KMT2D BRD4 YLPM1 | 4.15e-08 | 268 | 194 | 12 | 33640491 | |
| Pubmed | CDK12 FMNL2 GGA3 PTPN12 MCM3AP PKD1 PPP1R37 UBR4 FNBP4 NCOR2 KMT2D KLF10 PELP1 BRD4 YLPM1 LRP1 SON | 4.35e-08 | 591 | 194 | 17 | 15231748 | |
| Pubmed | Identification and functional characterization of transcriptional activators in human cells. | TET2 BCORL1 PRDM2 KMT2C SYNJ1 NFIB NFRKB EP400 BICRA PCLO NCOR2 KMT2D BRD4 MYO15A | 6.20e-08 | 398 | 194 | 14 | 35016035 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | CDK12 ZC3H13 BCORL1 ZNF207 NFRKB KMT2A MLLT6 EP400 BICRA FNBP4 ZBTB9 ICE1 NUP214 CHAMP1 NCOR2 SETD2 PELP1 BRD4 YLPM1 SPEN SON | 1.03e-07 | 954 | 194 | 21 | 36373674 |
| Pubmed | 1.71e-07 | 3 | 194 | 3 | 23932714 | ||
| Pubmed | EPS8 RAPH1 CDK12 WIPF3 SRCAP WASH6P SYNJ1 EP400 FNBP4 ZBTB9 SORBS1 BRD4 PHACTR4 YLPM1 SON | 1.90e-07 | 506 | 194 | 15 | 30890647 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | TRERF1 FOXA3 RCOR2 PRDM2 NFIB KMT2A MNT CUX2 TLX3 AKNA POU2F2 THAP1 MLXIPL KMT2D KLF10 MZF1 ATOH8 ZFHX2 SNAPC4 LYL1 | 2.09e-07 | 908 | 194 | 20 | 19274049 |
| Pubmed | ARHGAP32 RAPH1 NACA ZNF207 ARHGEF11 DOCK5 ASAP2 ARHGAP31 KMT2A DLAT PLEKHA7 ARAP1 BIN1 PRR36 ARHGEF5 NUP214 ARHGEF15 ARHGEF40 ARAP3 SMN1 | 2.40e-07 | 916 | 194 | 20 | 32203420 | |
| Pubmed | EPS8 CDK12 NACA ZNF207 KAT2A ARHGEF11 KMT2C NFIB NFRKB TNRC6A PXN KMT2A PLEKHA7 VARS1 CASC3 EP400 TAF1C WHAMM ICE1 COL18A1 SETD2 ABI2 SMN1 PRR11 SPEN SON | 3.03e-07 | 1497 | 194 | 26 | 31527615 | |
| Pubmed | 6.45e-07 | 13 | 194 | 4 | 16510874 | ||
| Pubmed | A subset of mixed lineage leukemia proteins has plant homeodomain (PHD)-mediated E3 ligase activity. | 6.81e-07 | 4 | 194 | 3 | 23129768 | |
| Pubmed | 6.81e-07 | 4 | 194 | 3 | 24081332 | ||
| Pubmed | 1.22e-06 | 15 | 194 | 4 | 35907431 | ||
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | EPS8 SETD1B BCORL1 SRCAP SYNJ1 MCM3AP TNRC6A NAV1 BSN EP400 TACC2 SORBS1 NCOR2 SETD2 SPEN | 1.25e-06 | 588 | 194 | 15 | 38580884 |
| Pubmed | NPIPB12 ZC3H13 OBSCN ZNF207 RNF214 PTPN12 PKD1 MICAL3 NEURL1B PLEKHA7 MNT DLGAP4 WASHC1 FNBP4 TACC2 CHAMP1 RPUSD1 COL18A1 NCOR2 ABI2 TNK2 ZNF385C | 1.35e-06 | 1215 | 194 | 22 | 15146197 | |
| Pubmed | 1.45e-06 | 35 | 194 | 5 | 20946988 | ||
| Pubmed | 1.62e-06 | 16 | 194 | 4 | 23870121 | ||
| Pubmed | 1.62e-06 | 16 | 194 | 4 | 24368734 | ||
| Pubmed | SETD1A SETD1B CDK12 ZC3H13 ZNF207 KMT2C KMT2A CHAMP1 KMT2D SPEN | 1.65e-06 | 251 | 194 | 10 | 31076518 | |
| Pubmed | 1.69e-06 | 5 | 194 | 3 | 25561738 | ||
| Pubmed | Characterization of the murine orthologue of a novel human subtelomeric multigene family. | 1.69e-06 | 5 | 194 | 3 | 11701968 | |
| Pubmed | ARHGAP32 NACA SYNJ1 TNRC6A NAV1 DLAT BSN VARS1 WNK2 SHANK1 BIN1 SGIP1 PCLO DLGAP4 UBR4 TACC2 SORBS1 SRCIN1 PDHX ANO8 ABI2 | 1.81e-06 | 1139 | 194 | 21 | 36417873 | |
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | CDK12 RC3H1 ZNF207 GIGYF1 KMT2C NFIB MCM3AP TNRC6A ATN1 NUP214 NCOR2 KMT2D YLPM1 | 2.01e-06 | 457 | 194 | 13 | 32344865 |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | ZC3H13 KAT2A RNF214 NFIB TNRC6A NAV1 WNK2 SHANK1 CASC3 PCLO NUP214 YLPM1 SMN1 | 2.26e-06 | 462 | 194 | 13 | 31138677 |
| Pubmed | Genetic interaction mapping in mammalian cells using CRISPR interference. | 2.50e-06 | 69 | 194 | 6 | 28481362 | |
| Pubmed | TRERF1 CDK12 NACA BCORL1 PTPN12 PCDH15 EP400 PCLO UBR4 NCOR2 PPP2R3A SPEN | 2.63e-06 | 396 | 194 | 12 | 26687479 | |
| Pubmed | ZNF207 BCL11A KAT2A KMT2C PCGF6 PXN KMT2A MNT CUX2 POU2F2 TACC2 CHAMP1 ATOH8 BRD4 ZNF746 ZFHX2 | 2.67e-06 | 709 | 194 | 16 | 22988430 | |
| Pubmed | Shotgun sequencing of the human transcriptome with ORF expressed sequence tags. | ARHGAP32 CDK12 FMNL2 PRDM2 DOCK5 TNRC6A MICAL3 ADAMTSL4 AFF2 ATN1 ADAMTS12 KMT2D ZFHX2 MAST3 | 3.06e-06 | 552 | 194 | 14 | 10737800 |
| Pubmed | Hdac4 Interactions in Huntington's Disease Viewed Through the Prism of Multiomics. | EPS8 ABI3 SETD1B WASH6P SYNJ1 NFRKB UBR4 WASHC1 NUP214 RABL6 NCOR2 INPP5J MAST3 | 3.06e-06 | 475 | 194 | 13 | 31040226 |
| Pubmed | TRERF1 ZC3H13 ZNF207 KAT2A SRCAP RCOR2 NUFIP1 NFIB PXN MLLT6 MNT CUX2 POU2F2 KLF10 BRD4 SMN1 SNAPC4 | 3.29e-06 | 808 | 194 | 17 | 20412781 | |
| Pubmed | 3.38e-06 | 6 | 194 | 3 | 34933446 | ||
| Pubmed | Human subtelomeric WASH genes encode a new subclass of the WASP family. | 3.38e-06 | 6 | 194 | 3 | 18159949 | |
| Pubmed | 3.48e-06 | 73 | 194 | 6 | 22094256 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | EFS BCL11A PRR16 WASH6P ADAMTSL4 SHANK1 CASC3 ATN1 DLGAP4 TACC2 SETD2 ABI2 SMN1 MAPK7 | 3.61e-06 | 560 | 194 | 14 | 21653829 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | SETD1A SRCAP MCM3AP KMT2A EP400 UBR4 CHAMP1 KMT2D YLPM1 SMN1 SPEN | 3.83e-06 | 341 | 194 | 11 | 32971831 |
| Pubmed | SETD1A SETD1B CDK12 RC3H1 RPS6KB2 KAT2A KMT2E PCGF6 KMT2A WNK2 ADAMTS12 MMP25 ZBTB45 MAP4K1 BRD4 LRP1 | 3.87e-06 | 730 | 194 | 16 | 34857952 | |
| Pubmed | E-cadherin interactome complexity and robustness resolved by quantitative proteomics. | ARHGAP32 RAPH1 FMNL2 GGA3 SYNJ1 PPP1R37 PXN PLEKHA7 SORBS1 SRCIN1 NUP214 CDC42EP1 PHACTR4 INAVA | 3.99e-06 | 565 | 194 | 14 | 25468996 |
| Pubmed | TRERF1 TET2 BCORL1 ZNF207 BCL11A KAT2A PRDM2 KMT2C NFRKB KMT2A MLLT6 MNT VARS1 EP400 BICRA ZBTB9 NCOR2 KMT2D BRD4 SPEN | 4.13e-06 | 1103 | 194 | 20 | 34189442 | |
| Pubmed | Resetting the epigenetic balance of Polycomb and COMPASS function at enhancers for cancer therapy. | 4.24e-06 | 20 | 194 | 4 | 29785026 | |
| Pubmed | ARHGAP32 RC3H1 NPHP4 FMNL2 ASAP2 TULP4 MICAL3 ARHGEF15 ANO8 SETD2 ZNF526 NEURL4 MAST3 | 4.57e-06 | 493 | 194 | 13 | 15368895 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | SPEG PAXX OBSCN ARHGEF11 DYSF KMT2C KMT2A MICAL3 FNBP4 SORBS1 SRCIN1 NUP214 RABL6 | 4.99e-06 | 497 | 194 | 13 | 36774506 |
| Pubmed | Broad histone H3K4me3 domains in mouse oocytes modulate maternal-to-zygotic transition. | 5.22e-06 | 21 | 194 | 4 | 27626377 | |
| Pubmed | CDK12 NACA BCORL1 ZNF207 NFRKB KMT2A CASC3 ATN1 BICRA PCLO FNBP4 PELP1 | 5.40e-06 | 425 | 194 | 12 | 24999758 | |
| Pubmed | A directed protein interaction network for investigating intracellular signal transduction. | EPS8 RIN3 RPS6KB2 KMT2C NRXN2 MCM3AP ASPSCR1 ARAP1 TAF1C DLGAP4 UBR4 ICE1 BAHD1 FBXL16 KLF10 BRD4 ZNF746 SMN1 WASH2P SNAPC4 | 5.46e-06 | 1124 | 194 | 20 | 21900206 |
| Pubmed | 5.88e-06 | 7 | 194 | 3 | 36598580 | ||
| Pubmed | 7.08e-06 | 233 | 194 | 9 | 37704626 | ||
| Pubmed | 7.36e-06 | 83 | 194 | 6 | 28794006 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | TET2 ARHGAP32 RAPH1 GIGYF1 SYNJ1 NAV1 KMT2A PLEKHA7 CASC3 ARHGEF5 SORBS1 CDC42EP1 MLXIPL MAP4K1 BRD4 PHACTR4 PROSER2 | 7.57e-06 | 861 | 194 | 17 | 36931259 |
| Pubmed | 7.65e-06 | 23 | 194 | 4 | 9225980 | ||
| Pubmed | An inducible CRISPR/Cas9 screen identifies DTX2 as a transcriptional regulator of human telomerase. | 8.36e-06 | 180 | 194 | 8 | 35198878 | |
| Pubmed | EPS8 BCORL1 WIPF3 ZNF207 GIGYF1 NUFIP1 KMT2C SYNJ1 NFIB MLLT6 COL12A1 TAF1C UBR4 WASHC1 SRCIN1 | 8.49e-06 | 689 | 194 | 15 | 36543142 | |
| Pubmed | 8.86e-06 | 50 | 194 | 5 | 37974198 | ||
| Pubmed | Differentially regulated and evolved genes in the fully sequenced Xq/Yq pseudoautosomal region. | 9.38e-06 | 8 | 194 | 3 | 10655549 | |
| Pubmed | Ca2+ entry through mechanotransduction channels localizes BAIAP2L2 to stereocilia tips. | 9.38e-06 | 8 | 194 | 3 | 35044843 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | OBSCN DOCK5 KMT2C ASAP2 TULP4 NFIB NAV1 ANTXR1 MICAL3 ASPSCR1 WNK2 ARAP1 CASC3 BICRA FNBP4 SRCIN1 ANO8 COL18A1 NCOR2 PPP2R3A LRP1 ZFHX2 TNK2 | 1.06e-05 | 1489 | 194 | 23 | 28611215 |
| Pubmed | 1.40e-05 | 9 | 194 | 3 | 21144999 | ||
| Pubmed | 1.40e-05 | 9 | 194 | 3 | 26691508 | ||
| Pubmed | SETD1A ZNF207 KMT2C PTPN12 TNRC6A KMT2A EP400 NUP214 KMT2D PELP1 BRD4 SPEN | 1.44e-05 | 469 | 194 | 12 | 27634302 | |
| Pubmed | 1.61e-05 | 197 | 194 | 8 | 36604605 | ||
| Pubmed | 1.93e-05 | 202 | 194 | 8 | 24639526 | ||
| Pubmed | 2.07e-05 | 335 | 194 | 10 | 15741177 | ||
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | TRADD RAPH1 GIGYF1 NUFIP1 MCM3AP NFKBIB PXN CASC3 TEPSIN TBC1D17 CDC42EP1 RABL6 MLXIPL SETD2 ARAP3 SMN1 PROSER2 MAPK7 | 2.31e-05 | 1038 | 194 | 18 | 26673895 |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 2.38e-05 | 208 | 194 | 8 | 33230847 | |
| Pubmed | 2.41e-05 | 102 | 194 | 6 | 10231032 | ||
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | SETD1A SETD1B BCORL1 BCL11A KMT2C PCGF6 NFRKB KMT2A MNT ATN1 CHAMP1 KMT2D | 2.45e-05 | 495 | 194 | 12 | 27705803 |
| Pubmed | 2.46e-05 | 152 | 194 | 7 | 38360978 | ||
| Pubmed | WIPF3 OBSCN KMT2E DYSF PCGF6 TRIM55 PXN BIN1 COL12A1 SORBS1 KLF10 SON | 2.55e-05 | 497 | 194 | 12 | 23414517 | |
| Pubmed | Identification and characterization of a novel human PP1 phosphatase complex. | 2.62e-05 | 31 | 194 | 4 | 20516061 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | EPS8 ARHGAP32 RAPH1 ARHGEF11 GGA3 SYNJ1 TNRC6A PXN MICAL3 PLEKHA7 SORBS1 PDHX PPP2R3A ABI2 PHACTR4 NEURL4 | 2.64e-05 | 853 | 194 | 16 | 28718761 |
| Pubmed | ARHGAP32 RAPH1 PPM1J PTPN12 TNRC6A PPP1R37 PXN MICAL3 PLEKHA7 TNS2 CDC42EP1 NCOR2 PPP2R3A KMT2D FBXL16 ABI2 YLPM1 NEURL4 | 2.65e-05 | 1049 | 194 | 18 | 27880917 | |
| Pubmed | Human CpG binding protein interacts with MLL1, MLL2 and hSet1 and regulates Hox gene expression. | 2.73e-05 | 11 | 194 | 3 | 18082152 | |
| Pubmed | 2.79e-05 | 347 | 194 | 10 | 17114649 | ||
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 25481287 | ||
| Pubmed | Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation. | 3.10e-05 | 2 | 194 | 2 | 23403927 | |
| Pubmed | SETD2-mediated crosstalk between H3K36me3 and H3K79me2 in MLL-rearranged leukemia. | 3.10e-05 | 2 | 194 | 2 | 29249820 | |
| Pubmed | Role of Bassoon and Piccolo in Assembly and Molecular Organization of the Active Zone. | 3.10e-05 | 2 | 194 | 2 | 26793095 | |
| Pubmed | 3.10e-05 | 2 | 194 | 2 | 20332206 | ||
| Interaction | TOP3B interactions | SETD1A RIN3 SETD1B CDK12 SPEG OBSCN KAT2A SRCAP ARHGEF11 DYSF NPHP4 ABCA7 GGA3 KMT2C TULP4 SYNJ1 MCM3AP A4GALT PKD1 PXN NAV1 MAP3K11 DLAT MLLT6 MICAL3 ADAMTSL4 WNK2 ARAP1 EP400 BICRA UBR4 AKNA ICE1 NUP214 BAHD1 TBC1D17 ANO8 RABL6 NCOR2 ARHGEF40 KMT2D ARAP3 SLC2A4RG KLF10 PELP1 BRD4 TNK2 SLC45A1 SNAPC4 SPEN | 5.17e-16 | 1470 | 189 | 50 | int:TOP3B |
| Interaction | NCK2 interactions | ARHGAP32 ABI3 RAPH1 EFS WIPF3 BCL11A PRR16 ASAP2 PTPN12 PKD1 PXN MNT ARAP1 ATN1 DLGAP4 SORBS1 DOK2 ZNF526 ABI2 MAP4K1 YLPM1 TNK2 | 5.81e-15 | 262 | 189 | 22 | int:NCK2 |
| Interaction | EGR2 interactions | TRERF1 TET2 BCORL1 BCL11A KMT2C PCGF6 NFRKB KMT2A ATN1 EP400 BICRA ZBTB9 NCOR2 KMT2D ZNF746 | 7.74e-11 | 171 | 189 | 15 | int:EGR2 |
| Interaction | CRX interactions | TRERF1 TET2 BCORL1 KAT2A KMT2C PCGF6 NFRKB MLLT6 ATN1 EP400 BICRA TLX3 TNS2 NCOR2 KMT2D ABI2 SPEN | 2.92e-10 | 254 | 189 | 17 | int:CRX |
| Interaction | TLE3 interactions | TRERF1 TET2 CDK12 BCORL1 ZNF207 FOXA3 NFIB MCM3AP NFRKB TNRC6A KMT2A MLLT6 ATN1 TLX3 NCOR2 SETD2 KMT2D BRD4 SPEN SON | 4.38e-10 | 376 | 189 | 20 | int:TLE3 |
| Interaction | NFIX interactions | SETD1A KAT2A SRCAP KMT2C NFIB NFRKB KMT2A EP400 BICRA TLX3 NCOR2 KMT2D ZNF746 SPEN | 3.23e-08 | 227 | 189 | 14 | int:NFIX |
| Interaction | CRK interactions | ARHGAP32 RIN3 EFS KMT2E GGA3 DOCK5 PXN ARAP1 BICRA ARHGEF5 ZBTB9 SRCIN1 DOK2 MAP4K1 BRD4 PHACTR4 SPEN | 8.08e-08 | 370 | 189 | 17 | int:CRK |
| Interaction | NUP43 interactions | SETD1A SETD1B CDK12 ZC3H13 SRCAP PRDM2 MCM3AP NFRKB KMT2A MLLT6 ATN1 EP400 ZBTB9 ICE1 NUP214 CHAMP1 NCOR2 SETD2 KMT2D PELP1 SPEN SON | 1.07e-07 | 625 | 189 | 22 | int:NUP43 |
| Interaction | KLF3 interactions | SETD1A BCORL1 BCL11A KAT2A PRDM2 PCGF6 NFIB NFRKB KMT2A EP400 ZBTB9 NCOR2 KMT2D | 2.53e-07 | 228 | 189 | 13 | int:KLF3 |
| Interaction | ACTG1 interactions | ARHGAP32 RIN3 RC3H1 RPS6KB2 WIPF3 SRCAP NPHP4 FMNL2 PTPN12 BIN1 EP400 WASHC1 WHAMM DOK2 ABI2 BRD4 PHACTR4 PRR11 MAPK7 | 4.78e-07 | 520 | 189 | 19 | int:ACTG1 |
| Interaction | KLF8 interactions | SETD1A BCORL1 KAT2A PRDM2 PCGF6 NFIB NFRKB ANTXR1 MNT BIN1 EP400 BICRA NCOR2 KMT2D SPEN | 5.32e-07 | 329 | 189 | 15 | int:KLF8 |
| Interaction | NCK1 interactions | ARHGAP32 EFS WIPF3 ASAP2 PTPN12 PXN ARAP1 DLGAP4 UBR4 DOK2 ABI2 MAP4K1 TNK2 | 5.48e-07 | 244 | 189 | 13 | int:NCK1 |
| Interaction | PIN1 interactions | EFS CDK12 BCL11A SELENOV MAP3K11 MLLT6 ADAMTSL4 ATN1 ZBTB9 TNS2 CHAMP1 ARHGEF15 NCOR2 ZNF526 ABI2 BRD4 | 7.05e-07 | 383 | 189 | 16 | int:PIN1 |
| Interaction | FEV interactions | SETD1A BCL11A KMT2C NFIB NFRKB KMT2A EP400 BICRA NCOR2 KMT2D ZNF746 | 3.55e-06 | 203 | 189 | 11 | int:FEV |
| Interaction | KMT2B interactions | 3.85e-06 | 130 | 189 | 9 | int:KMT2B | |
| Interaction | ASF1A interactions | ZC3H13 BCORL1 SRCAP PRDM2 NFRKB KMT2A MLLT6 EP400 BICRA NCOR2 KMT2D SPEN | 4.28e-06 | 249 | 189 | 12 | int:ASF1A |
| Interaction | BICD1 interactions | EPS8 ARHGAP32 RAPH1 HCN2 GGA3 SYNJ1 TNRC6A PXN NAV1 SORBS1 PPP2R3A ABI2 | 4.46e-06 | 250 | 189 | 12 | int:BICD1 |
| Interaction | KMT2C interactions | 4.94e-06 | 134 | 189 | 9 | int:KMT2C | |
| Interaction | PRPS2 interactions | SETD1A RIN3 NPHP4 PTPN12 NFRKB PXN ARHGEF5 DOK2 CHAMP1 INAVA SNAPC4 MAPK7 | 5.04e-06 | 253 | 189 | 12 | int:PRPS2 |
| Interaction | GRB2 interactions | EPS8 ARHGAP32 RIN3 ABI3 WIPF3 HCN2 DOCK5 ASAP2 PTPN12 SYNJ1 PXN PLEKHA7 ARAP1 CASC3 ARHGEF5 UBR4 TNS2 MLXIPL MAP4K1 PHACTR4 YLPM1 TNK2 | 7.22e-06 | 806 | 189 | 22 | int:GRB2 |
| Interaction | H3-3A interactions | CDKN1C SETD1A SETD1B BCORL1 KAT2A SRCAP PRDM2 KMT2C PCGF6 NFRKB KMT2A MLLT6 VARS1 ARHGEF5 ZBTB9 CHAMP1 KMT2D PELP1 BRD4 SNAPC4 SPEN | 7.89e-06 | 749 | 189 | 21 | int:H3-3A |
| Interaction | KDM1A interactions | TRERF1 TET2 RAPH1 BCORL1 RCOR2 PRDM2 SYNJ1 TNRC6A PXN NAV1 VARS1 EP400 UBR4 ZBTB9 ICE1 NUP214 CHAMP1 BAHD1 NCOR2 KMT2D PELP1 BRD4 LRP1 SMN1 | 8.44e-06 | 941 | 189 | 24 | int:KDM1A |
| Interaction | ACTC1 interactions | EPS8 RAPH1 CDK12 WIPF3 NAA80 BCL11A SRCAP NPHP4 WASH6P SYNJ1 WNK2 EP400 BICRA FNBP4 ZBTB9 SORBS1 BRD4 PHACTR4 YLPM1 SON | 8.82e-06 | 694 | 189 | 20 | int:ACTC1 |
| Interaction | SORBS2 interactions | 9.99e-06 | 111 | 189 | 8 | int:SORBS2 | |
| Interaction | HNF4A interactions | SETD1A KAT2A SRCAP KMT2C NFIB NFRKB EP400 BICRA ZBTB9 NCOR2 KMT2D SPEN | 1.17e-05 | 275 | 189 | 12 | int:HNF4A |
| Interaction | HNF1B interactions | 1.28e-05 | 190 | 189 | 10 | int:HNF1B | |
| Interaction | LMO1 interactions | 1.53e-05 | 154 | 189 | 9 | int:LMO1 | |
| Interaction | KANSL3 interactions | 1.64e-05 | 86 | 189 | 7 | int:KANSL3 | |
| Interaction | SORBS3 interactions | RIN3 EFS SYNJ1 ADAMTSL4 ARAP1 TEPSIN TNS2 SORBS1 SRCIN1 ABI2 | 2.18e-05 | 202 | 189 | 10 | int:SORBS3 |
| Interaction | DPY30 interactions | 2.37e-05 | 204 | 189 | 10 | int:DPY30 | |
| Interaction | SPANXN2 interactions | 3.15e-05 | 95 | 189 | 7 | int:SPANXN2 | |
| Interaction | SNRNP40 interactions | CDK12 RC3H1 ZC3H13 ZNF207 NUFIP1 NFRKB KMT2A MLLT6 VARS1 ATN1 EP400 ZBTB9 NCOR2 SETD2 PELP1 BRD4 SPEN SON | 3.28e-05 | 637 | 189 | 18 | int:SNRNP40 |
| Interaction | YWHAH interactions | TET2 ARHGAP32 RIN3 SPEG ZC3H13 RPS6KB2 GIGYF1 SYNJ1 NAV1 KMT2A PLEKHA7 WNK2 CASC3 ARHGEF5 TNS2 SORBS1 CDC42EP1 MLXIPL ABI2 BRD4 PHACTR4 PROSER2 MAPK7 MAST3 SMTNL2 | 3.87e-05 | 1102 | 189 | 25 | int:YWHAH |
| Interaction | ARHGAP12 interactions | 4.24e-05 | 68 | 189 | 6 | int:ARHGAP12 | |
| Interaction | PAX6 interactions | SRCAP KMT2C PCGF6 SYNJ1 NFIB NFRKB MLLT6 EP400 BICRA ZBTB9 NCOR2 KMT2D ZNF746 | 4.41e-05 | 366 | 189 | 13 | int:PAX6 |
| Interaction | NCOA6 interactions | 6.88e-05 | 145 | 189 | 8 | int:NCOA6 | |
| Interaction | SETD1B interactions | 7.40e-05 | 75 | 189 | 6 | int:SETD1B | |
| Interaction | PHF20L1 interactions | 7.40e-05 | 75 | 189 | 6 | int:PHF20L1 | |
| Interaction | EN1 interactions | 8.05e-05 | 110 | 189 | 7 | int:EN1 | |
| Interaction | BOD1L1 interactions | 8.33e-05 | 149 | 189 | 8 | int:BOD1L1 | |
| Interaction | RBBP5 interactions | SETD1A SETD1B ZC3H13 KMT2C TNRC6A KMT2A ATN1 KMT2D PELP1 BRD4 SPEN | 8.80e-05 | 287 | 189 | 11 | int:RBBP5 |
| Interaction | KLF12 interactions | 9.30e-05 | 194 | 189 | 9 | int:KLF12 | |
| Interaction | PHF21A interactions | BCORL1 RCOR2 SYNJ1 TNRC6A PXN NAV1 UBR4 ZBTB9 ICE1 NUP214 KMT2D BRD4 | 1.00e-04 | 343 | 189 | 12 | int:PHF21A |
| Interaction | HCFC1 interactions | SETD1A SETD1B KMT2E KMT2C KMT2A ATN1 EP400 THAP1 KMT2D PELP1 BRD4 | 1.06e-04 | 293 | 189 | 11 | int:HCFC1 |
| Interaction | ELF4 interactions | 1.07e-04 | 115 | 189 | 7 | int:ELF4 | |
| Interaction | TBXT interactions | 1.13e-04 | 116 | 189 | 7 | int:TBXT | |
| Interaction | HDAC1 interactions | TRERF1 TET2 RAPH1 BCL11A KMT2E RCOR2 PCGF6 SYNJ1 TNRC6A PXN NAV1 KMT2A MNT VARS1 EP400 UBR4 ZBTB9 NUP214 BAHD1 NCOR2 KMT2D BRD4 SMN1 SPEN | 1.14e-04 | 1108 | 189 | 24 | int:HDAC1 |
| Interaction | LASP1 interactions | 1.18e-04 | 247 | 189 | 10 | int:LASP1 | |
| Interaction | SOX7 interactions | 1.22e-04 | 82 | 189 | 6 | int:SOX7 | |
| Interaction | CBX8 interactions | BCORL1 GIGYF1 PCGF6 KMT2A TEPSIN ZBTB9 ICE1 CHAMP1 SETD2 BRD4 | 1.26e-04 | 249 | 189 | 10 | int:CBX8 |
| Interaction | SUPT5H interactions | BCL11A RNF214 NFRKB KMT2A EP400 BICRA UBR4 TNS2 ICE1 NCOR2 KMT2D BRD4 SPEN | 1.32e-04 | 408 | 189 | 13 | int:SUPT5H |
| Interaction | PHF20 interactions | 1.37e-04 | 53 | 189 | 5 | int:PHF20 | |
| Interaction | ELK3 interactions | 1.39e-04 | 120 | 189 | 7 | int:ELK3 | |
| Interaction | SP7 interactions | TRERF1 TET2 KAT2A KMT2C NFIB ATN1 EP400 BICRA NCOR2 KMT2D YLPM1 | 1.46e-04 | 304 | 189 | 11 | int:SP7 |
| Interaction | KDM6A interactions | 1.49e-04 | 162 | 189 | 8 | int:KDM6A | |
| Interaction | PCGF1 interactions | 1.58e-04 | 208 | 189 | 9 | int:PCGF1 | |
| Interaction | GSC interactions | 1.69e-04 | 87 | 189 | 6 | int:GSC | |
| Interaction | LHX4 interactions | 1.76e-04 | 166 | 189 | 8 | int:LHX4 | |
| Interaction | NHLH1 interactions | 1.80e-04 | 88 | 189 | 6 | int:NHLH1 | |
| Interaction | SMC5 interactions | CDK12 ZC3H13 BCORL1 ZNF207 NFRKB KMT2A MLLT6 EP400 BICRA FNBP4 ZBTB9 ICE1 NUP214 CHAMP1 NCOR2 SETD2 PELP1 BRD4 YLPM1 SMN1 SPEN SON | 1.81e-04 | 1000 | 189 | 22 | int:SMC5 |
| Interaction | FBXO22 interactions | CDKN1C SPEG PAXX OBSCN ARHGEF11 DYSF KMT2C KMT2A MICAL3 FNBP4 SORBS1 SRCIN1 NUP214 RABL6 NCOR2 | 1.83e-04 | 540 | 189 | 15 | int:FBXO22 |
| Interaction | ELF1 interactions | 1.88e-04 | 126 | 189 | 7 | int:ELF1 | |
| Interaction | NUP35 interactions | CDK12 RC3H1 ZNF207 GIGYF1 KMT2C NFIB MCM3AP TNRC6A ATN1 NUP214 NCOR2 KMT2D YLPM1 | 1.92e-04 | 424 | 189 | 13 | int:NUP35 |
| Interaction | BICD2 interactions | BORCS6 EPS8 RAPH1 SYNJ1 TNRC6A PXN PLEKHA7 TNS2 SORBS1 ARHGEF15 PPP2R3A ABI2 NEURL4 | 2.01e-04 | 426 | 189 | 13 | int:BICD2 |
| Interaction | ASH2L interactions | SETD1A SETD1B SRCAP KMT2E KMT2C TNRC6A KMT2A ICE1 KMT2D PELP1 | 2.09e-04 | 265 | 189 | 10 | int:ASH2L |
| Interaction | BIN1 interactions | 2.18e-04 | 129 | 189 | 7 | int:BIN1 | |
| Interaction | POLR1G interactions | RC3H1 BCORL1 SRCAP PRDM2 NFKBIB KMT2A EP400 BICRA TAF1C UBR4 ZBTB9 ICE1 PELP1 BRD4 | 2.21e-04 | 489 | 189 | 14 | int:POLR1G |
| Interaction | PHF1 interactions | 2.25e-04 | 172 | 189 | 8 | int:PHF1 | |
| Interaction | PAX9 interactions | 2.28e-04 | 130 | 189 | 7 | int:PAX9 | |
| Interaction | HCFC2 interactions | 2.30e-04 | 92 | 189 | 6 | int:HCFC2 | |
| Interaction | ZNF608 interactions | 2.44e-04 | 93 | 189 | 6 | int:ZNF608 | |
| Interaction | RERE interactions | 2.44e-04 | 93 | 189 | 6 | int:RERE | |
| Interaction | CXXC1 interactions | 2.51e-04 | 132 | 189 | 7 | int:CXXC1 | |
| Interaction | KCTD13 interactions | EPS8 ARHGAP32 BCL11A ARHGEF11 FMNL2 NRXN2 SYNJ1 NAV1 KMT2A DLAT MICAL3 BSN PLEKHA7 VARS1 WNK2 SHANK1 BIN1 SGIP1 PRR36 PCLO DLGAP4 SORBS1 SRCIN1 PDHX MLXIPL THBS4 FBXL16 | 2.62e-04 | 1394 | 189 | 27 | int:KCTD13 |
| Interaction | MYB interactions | 2.63e-04 | 133 | 189 | 7 | int:MYB | |
| Interaction | ERG interactions | 2.65e-04 | 223 | 189 | 9 | int:ERG | |
| Interaction | YWHAG interactions | TET2 ARHGAP32 RAPH1 CDK12 SPEG RC3H1 ZC3H13 GIGYF1 SYNJ1 NAV1 KMT2A PLEKHA7 CASC3 ARHGEF5 TNS2 SORBS1 CDC42EP1 MLXIPL PHACTR4 TNK2 PROSER2 MAPK7 MAST3 SMTNL2 SON | 2.73e-04 | 1248 | 189 | 25 | int:YWHAG |
| Interaction | KAT8 interactions | 2.73e-04 | 95 | 189 | 6 | int:KAT8 | |
| Interaction | EPS8 interactions | 3.01e-04 | 136 | 189 | 7 | int:EPS8 | |
| Interaction | CRKL interactions | 3.02e-04 | 227 | 189 | 9 | int:CRKL | |
| Interaction | TRIM37 interactions | BORCS6 NACA GIGYF1 NPHP4 ARHGAP31 MCM3AP NFRKB TNRC6A NAV1 DLAT NCOR2 KMT2D ZNF746 LRP1 SNAPC4 SPEN | 3.06e-04 | 630 | 189 | 16 | int:TRIM37 |
| Interaction | AFDN interactions | ARHGAP32 GIGYF1 FMNL2 NRXN2 TNRC6A KMT2A MLLT6 PLEKHA7 SORBS1 PHACTR4 TNK2 | 3.20e-04 | 333 | 189 | 11 | int:AFDN |
| Interaction | ZZZ3 interactions | 3.44e-04 | 139 | 189 | 7 | int:ZZZ3 | |
| Interaction | ZCCHC10 interactions | 4.01e-04 | 236 | 189 | 9 | int:ZCCHC10 | |
| Interaction | MED29 interactions | 4.01e-04 | 102 | 189 | 6 | int:MED29 | |
| Interaction | MYO15A interactions | 4.16e-04 | 16 | 189 | 3 | int:MYO15A | |
| Interaction | AR interactions | TRERF1 TET2 SRCAP KMT2C NFIB NFRKB PXN KMT2A ATN1 EP400 TLX3 ZBTB9 POU2F2 CHAMP1 NCOR2 KMT2D PELP1 BRD4 YLPM1 TNK2 SON | 4.26e-04 | 992 | 189 | 21 | int:AR |
| Interaction | VASP interactions | 4.76e-04 | 294 | 189 | 10 | int:VASP | |
| Interaction | ITSN2 interactions | 4.82e-04 | 147 | 189 | 7 | int:ITSN2 | |
| Interaction | MYOD1 interactions | 5.03e-04 | 194 | 189 | 8 | int:MYOD1 | |
| Interaction | KANSL2 interactions | 5.08e-04 | 70 | 189 | 5 | int:KANSL2 | |
| Interaction | IGFL2 interactions | 5.18e-04 | 4 | 189 | 2 | int:IGFL2 | |
| Interaction | MPEG1 interactions | 5.18e-04 | 4 | 189 | 2 | int:MPEG1 | |
| Interaction | SRC interactions | EPS8 ARHGAP32 EFS RPS6KB2 HCN2 PRDM2 ASAP2 PKD1 PXN KMT2A SORBS1 SRCIN1 DOK2 PELP1 LRP1 TNK2 | 5.43e-04 | 664 | 189 | 16 | int:SRC |
| Interaction | SRGAP2 interactions | 5.57e-04 | 197 | 189 | 8 | int:SRGAP2 | |
| Interaction | YWHAB interactions | TET2 ARHGAP32 RIN3 SPEG RC3H1 GIGYF1 NAV1 KMT2A PLEKHA7 CASC3 BIN1 ARHGEF5 TNS2 SORBS1 CDC42EP1 ABI2 PHACTR4 MAPK7 MAST3 SMTNL2 SON | 5.66e-04 | 1014 | 189 | 21 | int:YWHAB |
| Interaction | PRR20A interactions | 5.72e-04 | 109 | 189 | 6 | int:PRR20A | |
| Interaction | AMPH interactions | 5.79e-04 | 72 | 189 | 5 | int:AMPH | |
| Interaction | PHC2 interactions | 6.12e-04 | 153 | 189 | 7 | int:PHC2 | |
| Interaction | E2F1 interactions | 6.15e-04 | 200 | 189 | 8 | int:E2F1 | |
| Cytoband | 16p11.2 | 1.72e-04 | 191 | 194 | 6 | 16p11.2 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 8.38e-11 | 34 | 129 | 8 | 487 | |
| GeneFamily | Wiskott-Aldrich Syndrome protein family | 4.21e-06 | 16 | 129 | 4 | 14 | |
| GeneFamily | Ataxins|Trinucleotide repeat containing | 2.79e-05 | 25 | 129 | 4 | 775 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 3.73e-05 | 53 | 129 | 5 | 532 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.08e-04 | 66 | 129 | 5 | 722 | |
| GeneFamily | PHD finger proteins | 4.63e-04 | 90 | 129 | 5 | 88 | |
| GeneFamily | ArfGAPs | 1.66e-03 | 33 | 129 | 3 | 395 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 1.76e-03 | 9 | 129 | 2 | 1280 | |
| GeneFamily | Ankyrin repeat domain containing | 1.77e-03 | 242 | 129 | 7 | 403 | |
| GeneFamily | PDZ domain containing | 4.70e-03 | 152 | 129 | 5 | 1220 | |
| GeneFamily | Zinc fingers|Zinc fingers PARP-type|Poly(ADP-ribose) polymerases | 4.99e-03 | 15 | 129 | 2 | 26 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | SETD1A GIGYF1 SRCAP ARHGEF11 ABCA7 RNF214 VARS1 TEPSIN ATN1 BICRA TAF1C FNBP4 NUP214 CDC42EP1 KMT2D TNK2 SNAPC4 NEURL4 | 7.65e-11 | 338 | 193 | 18 | M17094 |
| Coexpression | GSE16385_MONOCYTE_VS_12H_IL4_TREATED_MACROPHAGE_DN | BORCS6 RIN3 ABI3 RPS6KB2 NAA80 ABCA7 NFRKB PPP1R37 MAP3K11 MLLT6 WASHC1 WHAMM PPP2R3A SNAPC4 | 3.06e-10 | 200 | 193 | 14 | M7904 |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | OBSCN FAM89B PRDM2 NRXN2 MCM3AP PKD1 KMT2A BIN1 PCLO POU2F2 SRCIN1 RABL6 COL18A1 NCOR2 PHACTR4 SLC45A1 SNAPC4 MAST3 | 7.37e-10 | 389 | 193 | 18 | M39102 |
| Coexpression | GSE20715_WT_VS_TLR4_KO_LUNG_DN | ABCA7 ARHGAP31 TNRC6A PPP1R37 MAP3K11 KMT2A VARS1 WASHC1 TBC1D17 BRD4 MAPK7 SPEN | 3.12e-08 | 199 | 193 | 12 | M4350 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | RAPH1 SPEG PDZD7 BCL11A GIGYF1 KMT2E FMNL2 RCOR2 PRDM2 NRXN2 TULP4 SYNJ1 TNRC6A NAV1 MICAL3 BSN AFF2 PCLO POU2F2 SORBS1 SRCIN1 ANO8 PPP2R3A FBXL16 MEGF9 ZFHX2 TNK2 | 4.75e-08 | 1106 | 193 | 27 | M39071 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_GHRL_POS_NE_PRECURSOR_CELL | ARHGAP32 BCORL1 ARHGEF11 FOXA3 RCOR2 A4GALT PKD1 NAV1 MICAL3 WNK2 COL12A1 PCLO POU2F2 BAHD1 MEGF9 ZFHX2 | 1.34e-07 | 429 | 193 | 16 | M45694 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | CDKN1C PAXX KAT2A DYSF ADAM8 GGA3 MCM3AP ASPSCR1 MNT TEPSIN BICRA TAF1C UBR4 WASHC1 ZNF526 KLF10 MZF1 MAP4K1 ZNF746 PHACTR4 TNK2 SPEN MAST3 | 2.55e-07 | 905 | 193 | 23 | M40865 |
| Coexpression | GSE46606_IRF4MID_VS_WT_CD40L_IL2_IL5_DAY1_STIMULATED_BCELL_UP | EPS8 GIGYF1 KAT2A B3GNT8 KMT2C NEURL1B MNT ZBTB45 SLC2A4RG LYL1 MAST3 | 2.86e-07 | 199 | 193 | 11 | M9850 |
| Coexpression | GSE28737_FOLLICULAR_VS_MARGINAL_ZONE_BCELL_BCL6_HET_UP | 2.48e-06 | 200 | 193 | 10 | M9354 | |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 4.13e-06 | 166 | 193 | 9 | M6826 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | SETD1B ADAM8 GGA3 ASPSCR1 MNT TEPSIN BICRA TAF1C WASHC1 WHAMM ZNF526 KLF10 MZF1 MAP4K1 PHACTR4 TNK2 SPEN | 5.07e-06 | 634 | 193 | 17 | M40866 |
| Coexpression | RUTELLA_RESPONSE_TO_HGF_DN | CDKN1C TRADD SETD1B ADAM8 NUP214 ARHGEF40 KLF10 MAP4K1 TNK2 SON | 1.24e-05 | 240 | 193 | 10 | M6413 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | TRERF1 ABI3 PAXX FAM89B KMT2E ADAM8 PRDM2 KMT2C KMT2A MLLT6 BIN1 EP400 UBR4 FNBP4 AKNA POU2F2 ICE1 DOK2 SETD2 KMT2D SLC2A4RG CD8A MAP4K1 TNK2 SPEN MAST3 SON | 1.45e-05 | 1492 | 193 | 27 | M40023 |
| Coexpression | GSE9988_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN | 1.71e-05 | 198 | 193 | 9 | M5861 | |
| Coexpression | GSE9988_LOW_LPS_VS_VEHICLE_TREATED_MONOCYTE_DN | 1.78e-05 | 199 | 193 | 9 | M5874 | |
| Coexpression | GSE40655_FOXO1_KO_VS_WT_NTREG_UP | 1.85e-05 | 200 | 193 | 9 | M9439 | |
| Coexpression | GSE26351_UNSTIM_VS_WNT_PATHWAY_STIM_HEMATOPOIETIC_PROGENITORS_UP | ARHGAP31 NFRKB BANK1 TAF1C CHAMP1 TBC1D17 KLF10 PHACTR4 MAST3 | 1.85e-05 | 200 | 193 | 9 | M8482 |
| Coexpression | KAECH_DAY15_EFF_VS_MEMORY_CD8_TCELL_UP | 1.85e-05 | 200 | 193 | 9 | M3030 | |
| Coexpression | TRAVAGLINI_LUNG_NEUTROPHIL_CELL | FAM89B GIGYF1 DYSF ADAM8 NPIPB13 WASHC1 POU2F2 MMP25 ARHGEF40 MEGF9 BRD4 MAST3 | 1.88e-05 | 366 | 193 | 12 | M41688 |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_TREG_CD4_TCELL_DN | 2.04e-05 | 155 | 193 | 8 | M8944 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_POSITIVE | TET2 RIN3 PPM1J DYSF DOCK5 NFKBIB MAP3K11 ADAMTSL4 MNT BANK1 SHANK1 CUX2 POU2F2 ANO8 CDC42EP1 NCOR2 ARHGEF40 ELL2 KLF10 ZNF746 CD68 MAPK7 C4orf46 | 5.12e-05 | 1250 | 193 | 23 | M41099 |
| Coexpression | PGF_UP.V1_DN | 8.66e-05 | 190 | 193 | 8 | M2673 | |
| Coexpression | GSE17974_IL4_AND_ANTI_IL12_VS_UNTREATED_4H_ACT_CD4_TCELL_UP | 1.00e-04 | 194 | 193 | 8 | M4213 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_VEHICLE_TREATED_MONOCYTES_DN | 1.11e-04 | 197 | 193 | 8 | M5853 | |
| Coexpression | GSE25123_WT_VS_PPARG_KO_MACROPHAGE_IL4_AND_ROSIGLITAZONE_STIM_DN | 1.11e-04 | 197 | 193 | 8 | M7921 | |
| Coexpression | GSE16266_CTRL_VS_LPS_STIM_MEF_UP | 1.15e-04 | 198 | 193 | 8 | M7219 | |
| Coexpression | ENK_UV_RESPONSE_EPIDERMIS_DN | CDKN1C EFS ZNF207 BCL11A PRDM2 NUFIP1 TULP4 NFIB KMT2A TACC2 NCOR2 ELL2 SLC2A4RG | 1.17e-04 | 512 | 193 | 13 | M4508 |
| Coexpression | GSE8621_UNSTIM_VS_LPS_PRIMED_AND_LPS_STIM_MACROPHAGE_DN | 1.19e-04 | 199 | 193 | 8 | M6987 | |
| Coexpression | GSE9988_ANTI_TREM1_VS_CTRL_TREATED_MONOCYTES_DN | 1.24e-04 | 200 | 193 | 8 | M5851 | |
| Coexpression | GSE9988_LPS_VS_CTRL_TREATED_MONOCYTE_DN | 1.24e-04 | 200 | 193 | 8 | M5859 | |
| Coexpression | GSE9988_LOW_LPS_VS_CTRL_TREATED_MONOCYTE_DN | 1.24e-04 | 200 | 193 | 8 | M5870 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 1.24e-04 | 200 | 193 | 8 | M9889 | |
| Coexpression | GSE29618_MONOCYTE_VS_PDC_DAY7_FLU_VACCINE_UP | 1.24e-04 | 200 | 193 | 8 | M4963 | |
| Coexpression | GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_DN | 1.24e-04 | 200 | 193 | 8 | M6208 | |
| Coexpression | GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN | 1.24e-04 | 200 | 193 | 8 | M9002 | |
| Coexpression | BUSSLINGER_DUODENAL_IMMUNE_CELLS | TRADD RIN3 ABI3 PAXX FAM89B ZNF207 KMT2E ADAM8 PRDM2 KMT2A MLLT6 BIN1 AKNA POU2F2 CD8A MAP4K1 TNK2 SON | 1.47e-04 | 911 | 193 | 18 | M40038 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HNBML5 | SPEG PDZD7 BCL11A RCOR2 NRXN2 NAV1 BSN AFF2 POU2F2 SRCIN1 PPP2R3A ZFHX2 | 1.84e-04 | 465 | 193 | 12 | M39066 |
| Coexpression | CUI_TCF21_TARGETS_2_DN | CDKN1C ABI3 SPEG WIPF3 FMNL2 DOCK5 KMT2C PTPN12 ARHGAP31 COL12A1 SGIP1 TNS2 SORBS1 ARHGEF15 ELL2 DAAM2 SON | 2.07e-04 | 854 | 193 | 17 | M1533 |
| Coexpression | SMID_BREAST_CANCER_NORMAL_LIKE_UP | CDKN1C BCL11A NRXN2 BANK1 BIN1 SORBS1 DOK2 COL18A1 CD8A MAP4K1 LYL1 MAST3 | 2.70e-04 | 485 | 193 | 12 | M8513 |
| Coexpression | HAY_BONE_MARROW_MONOCYTE | 2.84e-04 | 226 | 193 | 8 | M39201 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | TRERF1 PRR16 ANTXR1 NEURL1B COL12A1 SGIP1 SORBS1 ADAMTS12 LRP1 DAAM2 | 1.53e-08 | 195 | 194 | 10 | edd4cd8402af81737b2074f9dce71cc6ab09be7e |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | EPS8 SPEG PRR16 ANTXR1 NEURL1B COL12A1 SGIP1 SORBS1 ADAMTS12 DAAM2 | 1.61e-08 | 196 | 194 | 10 | b8759e6231e0254797d6c30930407b79440c57bb |
| ToppCell | mild-Non-classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.95e-08 | 200 | 194 | 10 | 334bab6bf93d455f3526e817ea5785d8b6ee531c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | TRERF1 SPEG PRR16 ANTXR1 NEURL1B COL12A1 SORBS1 ADAMTS12 DAAM2 | 1.60e-07 | 190 | 194 | 9 | 70c86dd454afb21d4a85db56c5f369d4b342bc97 |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DYSF ASAP2 ARHGAP31 NFIB MAP3K11 SORBS1 ARHGEF15 ARAP3 PHACTR4 | 1.83e-07 | 193 | 194 | 9 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | DYSF ASAP2 ARHGAP31 NFIB MAP3K11 SORBS1 ARHGEF15 ARAP3 PHACTR4 | 1.83e-07 | 193 | 194 | 9 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|COVID-19_Moderate / disease group, cell group and cell class | 2.09e-07 | 196 | 194 | 9 | 256c557fa11414c9d2cbb1fcff33f482ee1c78ac | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | TRERF1 PRR16 NEURL1B COL12A1 SGIP1 SORBS1 ADAMTS12 LRP1 DAAM2 | 2.18e-07 | 197 | 194 | 9 | ae0435f4b4a9cdedb1c201fc56921048390097bf |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | TRERF1 PRR16 NEURL1B COL12A1 SGIP1 SORBS1 ADAMTS12 LRP1 DAAM2 | 2.18e-07 | 197 | 194 | 9 | 37f6b6f2809b952382eaebb642b0aad6371f4251 |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | TRERF1 EPS8 PRR16 ANTXR1 COL12A1 SGIP1 SORBS1 ADAMTS12 DAAM2 | 2.27e-07 | 198 | 194 | 9 | 79576525a10ed3e3a9d1608077cd16ecda23376f |
| ToppCell | mLN-(5)_Dendritic_cell-(53)_Lymphoid_DC|mLN / shred on region, Cell_type, and subtype | 2.27e-07 | 198 | 194 | 9 | da84c76afe835aeee39da04b63c03549218b5d91 | |
| ToppCell | mLN-Dendritic_cell-Lymphoid_DC|mLN / Region, Cell class and subclass | 2.27e-07 | 198 | 194 | 9 | 3965a9f1e8a51a196e5349aaca5fa5ed1cd8ee92 | |
| ToppCell | lymphoid-NK_cell-NK_cell|NK_cell / Lineage, cell class and subclass | 2.37e-07 | 199 | 194 | 9 | 945fbf5845403a8b22d04963f50ad69c414b6153 | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.48e-07 | 200 | 194 | 9 | 934c2efc780318c66d667ca75be0de350361d351 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.48e-07 | 200 | 194 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | facs-Aorta-Heart-24m-Myeloid-macrophage|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.52e-07 | 173 | 194 | 8 | d0d1c8bcef3d9c28ee9a7c64076624b836cb2580 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.45e-06 | 183 | 194 | 8 | 667717366cb181b8a04a347e64f0f5a4dfc6ee7f | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.64e-06 | 186 | 194 | 8 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell|Adult / Lineage, Cell type, age group and donor | 1.71e-06 | 187 | 194 | 8 | 62759efb660179402fb574ce5701c89a2e17bcfe | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.78e-06 | 188 | 194 | 8 | b2d68a32314e9b099ed74d974079ad96359d1ae3 | |
| ToppCell | Control-Endothelial-Endothelial-Alv_Gen_Intermediate|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.85e-06 | 189 | 194 | 8 | 5d7ae1ead7f4fbaeec26f651833c9c2106e1e4d1 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.92e-06 | 190 | 194 | 8 | 4eb92aef1ee868f4537483d19014d947b7684612 | |
| ToppCell | nucseq-Mesenchymal-Myocytic-Myocytic_1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.92e-06 | 190 | 194 | 8 | 7be4341e2909101d756f14031c21e705eb45e69a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 191 | 194 | 8 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 191 | 194 | 8 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | COVID-19-kidney-vSMC/Pericyte|kidney / Disease (COVID-19 only), tissue and cell type | 2.00e-06 | 191 | 194 | 8 | fad8eaa536001b911d05ae2b12150c2398cc6f88 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 2.00e-06 | 191 | 194 | 8 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 191 | 194 | 8 | 1caf726bd07fdca389e678fc16304a6ef1790423 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 191 | 194 | 8 | 3d60c46bced2984c27a1fcf2910bc38b31fb0148 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.08e-06 | 192 | 194 | 8 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 193 | 194 | 8 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | normal-na-Myeloid-non-classical_monocyte-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.16e-06 | 193 | 194 | 8 | 053adc7ed9f997b503e12239a684bb9f5896e10c | |
| ToppCell | nucseq-Mesenchymal-Myocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.24e-06 | 194 | 194 | 8 | 2d66091097e106c7bee22e5281f50724700bdf8d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-06 | 194 | 194 | 8 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | IPF-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 2.24e-06 | 194 | 194 | 8 | 3892b188f424ffb80f3c75a1b6709a21c1e1601d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-06 | 194 | 194 | 8 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-06 | 194 | 194 | 8 | e03ba6caed59fa64d4d9b042593469d4a6a3dc10 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-06 | 194 | 194 | 8 | ebb038f94f49f5c655578d1b018676e10c6b7e3c | |
| ToppCell | COVID-19-kidney-Fibroblast-2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.33e-06 | 195 | 194 | 8 | 3d62ce1c696f47d4d7eb0c5bb0eec2c24b122bb2 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-06 | 195 | 194 | 8 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-06 | 195 | 194 | 8 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-06 | 195 | 194 | 8 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | Influenza_Severe-Non-classical_Monocyte|World / Disease group and Cell class | 2.42e-06 | 196 | 194 | 8 | 8ef9810ee99082a9c803c7ecad6ceb5710d16b54 | |
| ToppCell | COVID-19_Severe-Non-classical_Monocyte|COVID-19_Severe / disease group, cell group and cell class | 2.42e-06 | 196 | 194 | 8 | af9e8f5ef9d03862f707e105857309b55595b1b9 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.42e-06 | 196 | 194 | 8 | 51fc8bb9a806f8fbf78d5d80d535f1068a9770c2 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-06 | 196 | 194 | 8 | fa445f4240c521cf04eb2e2f79a5c55fda31209a | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.42e-06 | 196 | 194 | 8 | 802f61e78a9a1030a86c4a980c398a73cd4d1574 | |
| ToppCell | COVID-19-kidney-VWF+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 2.42e-06 | 196 | 194 | 8 | b71b197cb92117dd9efaa13de000841901cc4ca8 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_NK|bone_marrow / Manually curated celltypes from each tissue | 2.42e-06 | 196 | 194 | 8 | 1868ad537b7f04cdad0a0c8282aadbc4f257a722 | |
| ToppCell | Healthy/Control-Non-classical_Monocyte|World / Disease group and Cell class | 2.51e-06 | 197 | 194 | 8 | 470784932e1fc3ff69f27cd83f56d85b0c01af63 | |
| ToppCell | COVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type | 2.51e-06 | 197 | 194 | 8 | 7e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-06 | 197 | 194 | 8 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | URO-Myeloid-CD16_Mono|URO / Disease, Lineage and Cell Type | 2.51e-06 | 197 | 194 | 8 | 0201ba77419487e75edd5ea07ad7e5cbe87757d4 | |
| ToppCell | normal-na-Myeloid-non-classical_monocyte-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.61e-06 | 198 | 194 | 8 | d91bd26e499637949768587603cad3c03dcc56e7 | |
| ToppCell | severe-HLA-DR+_CD83+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.61e-06 | 198 | 194 | 8 | a77f3440d7fb6a50066abc7e9ad59e83798ef13d | |
| ToppCell | normal-na-Myeloid-non-classical_monocyte|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.61e-06 | 198 | 194 | 8 | f5a12861e2b8ff8309f3e4d0ad83d4f6860cc616 | |
| ToppCell | COVID-19_Moderate-Non-classical_Monocyte|World / disease group, cell group and cell class | 2.61e-06 | 198 | 194 | 8 | 8449934e20bb2a34079fb642cae0d4647b9efe51 | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.61e-06 | 198 | 194 | 8 | 35499a5231818e3432cf69b5c4a58c02f7771db8 | |
| ToppCell | Healthy_donor-Non-classical_Monocyte|World / disease group, cell group and cell class (v2) | 2.61e-06 | 198 | 194 | 8 | 8a97c8b2a43e6d1e669ce18752841e2006744bd9 | |
| ToppCell | Transverse-Dendritic_cell-cDC1|Transverse / Region, Cell class and subclass | 2.71e-06 | 199 | 194 | 8 | b68419939d206417158a703f60a374bf8ec5d5a1 | |
| ToppCell | Transverse-(5)_Dendritic_cell-(51)_cDC1|Transverse / shred on region, Cell_type, and subtype | 2.71e-06 | 199 | 194 | 8 | 52dd1c4cd372f8ee515307a9200e357bb2145888 | |
| ToppCell | Parenchymal-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 199 | 194 | 8 | dc88ce36cc066eb6c28cfd5b9b60fe07f8cc7b53 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.71e-06 | 199 | 194 | 8 | fa5ad81554969fffe5e779614d071d9194a7182c | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate|5w / Sample Type, Dataset, Time_group, and Cell type. | 2.81e-06 | 200 | 194 | 8 | c92e4fc0442404481fcac623d691dae6215b852d | |
| ToppCell | control-Neutrophil|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.81e-06 | 200 | 194 | 8 | b5d197472799cc61d7497faed91ac2564ae4930a | |
| ToppCell | Sepsis-URO-Myeloid-CD16+_Monocyte|URO / Disease, condition lineage and cell class | 2.81e-06 | 200 | 194 | 8 | 82408dac860899510a1f5849d2b0b1692053fb96 | |
| ToppCell | Sepsis-Bac-SEP-Myeloid-CD16+_Monocyte|Bac-SEP / Disease, condition lineage and cell class | 2.81e-06 | 200 | 194 | 8 | 4916075ec845733fc4cc1ae61964af7abcf28901 | |
| ToppCell | mild-Non-classical_Monocyte|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.81e-06 | 200 | 194 | 8 | 692b48da9fd56bafcb3c8b33b0fe369160881c45 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.63e-06 | 156 | 194 | 7 | 44ff0acdd5cc3575d6c24a1c2ba11cd9f55359d1 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.63e-06 | 156 | 194 | 7 | 55ba43cec9d79f309e9f633a6469cf03bb621e64 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 9.51e-06 | 169 | 194 | 7 | c7fc3a8c44f07c557b60d469717b66e2f5863d38 | |
| ToppCell | CTRL-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 9.88e-06 | 170 | 194 | 7 | 151dabe1d240dde414c881bf4fa816c69fa1c32d | |
| ToppCell | B_cell|World / lung cells shred on cell class, cell subclass, sample id | 9.88e-06 | 170 | 194 | 7 | cec4090ba6a9c934d5f6f9e4aa7823f3713319b7 | |
| ToppCell | Control-Fibroblasts-Pericytes|Control / group, cell type (main and fine annotations) | 1.03e-05 | 171 | 194 | 7 | 080003f698f867935c2bfc55d241d3650f45a0ab | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.03e-05 | 171 | 194 | 7 | 656a9f407461dbf5c9c0bd234399e1fef6abce2a | |
| ToppCell | CTRL-Myeloid-Neutrophil|CTRL / Disease state, Lineage and Cell class | 1.07e-05 | 172 | 194 | 7 | ef3a6fe3b7300959f9f71130200c7fb8741c42b0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-vascular_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.11e-05 | 173 | 194 | 7 | 5416b092321c7d9b63f0418c60f2402a138355bf | |
| ToppCell | facs-Pancreas-Exocrine-3m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.15e-05 | 174 | 194 | 7 | f1fe1f4216748a9562dd03bd48c70b23c7ff4d1d | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-05 | 175 | 194 | 7 | c1c722db42da9b8a2a46e516ddb83d9be5e2e504 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Rectal_Adenocarcinoma-7|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 1.33e-05 | 178 | 194 | 7 | edc76b8f15056ec1c9a1c61a048b6331a92592d6 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.38e-05 | 179 | 194 | 7 | 8f9e538c822940785130297712b75131812a4603 | |
| ToppCell | droplet-Fat-Gat-18m-Endothelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.38e-05 | 179 | 194 | 7 | 08cf9986804a6417a9afb19b50c69a3554f71ec6 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-CD141+_DCs|normal_Lymph_Node / Location, Cell class and cell subclass | 1.38e-05 | 179 | 194 | 7 | ec995ccd6e1dbd06287ad836c232d9aed1cf94a8 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 1.38e-05 | 179 | 194 | 7 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | RV|World / Chamber and Cluster_Paper | 1.48e-05 | 181 | 194 | 7 | bbe1e6e59d8889bd37d6e8303116cbdcafca7236 | |
| ToppCell | COVID-19-Heart-CM_3|Heart / Disease (COVID-19 only), tissue and cell type | 1.54e-05 | 182 | 194 | 7 | 287fcc3897ae08841f6f85ae6c9cef16f75b1dd1 | |
| ToppCell | RV-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.59e-05 | 122 | 194 | 6 | 1cb1dd03b2aaedbe04f3ed907568c3b7f54767b3 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.59e-05 | 183 | 194 | 7 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | Adult-Mesenchymal-pericyte_cell-D122|Adult / Lineage, Cell type, age group and donor | 1.59e-05 | 183 | 194 | 7 | fc31a43a637423cb3bb9aa184a3a889a0b9aaea6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 184 | 194 | 7 | c5436a8e45f471b8d1301abbe9c7879204537f52 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-05 | 184 | 194 | 7 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_B-Branch_B3_(IPAN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.71e-05 | 185 | 194 | 7 | edb114487206e4e8df4c7878285df40f49b7fd64 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 185 | 194 | 7 | 51dfe6ac7df8b330343b37e3bee71e5c65267189 | |
| ToppCell | COVID-19-Fibroblasts-Pericytes|COVID-19 / group, cell type (main and fine annotations) | 1.71e-05 | 185 | 194 | 7 | 4905adaeeffd353e089578e5ea614437dbe794e6 | |
| ToppCell | facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l54|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.71e-05 | 185 | 194 | 7 | 59acaf025353405948dc34ccccf37ec5c08ea903 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-05 | 185 | 194 | 7 | a8c02cec3c414f3a0da9f2d6d28ce563b0030705 | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.77e-05 | 186 | 194 | 7 | f07e0c0d9c80ac9d8d679950e7d0c812becb85a3 | |
| ToppCell | COVID-19-kidney-Fibroblast-1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.83e-05 | 187 | 194 | 7 | 76bfe8c42430a230a8bdf299575c444fb7780f24 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 187 | 194 | 7 | ac8e092b37e042975e2ee057d3f7c6821e58e8b5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-05 | 187 | 194 | 7 | d591a3c216997663ab77710fed0d230ffc37e41a | |
| Drug | Flecainide acetate [54143-56-5]; Up 200; 8.4uM; MCF7; HT_HG-U133A | SPEG ZC3H13 BCL11A SRCAP ARHGEF11 ADAM8 NFIB MCM3AP PPP1R37 KMT2A KMT2D DAAM2 | 9.53e-08 | 195 | 190 | 12 | 3843_UP |
| Drug | Nifenazone [2139-47-1]; Down 200; 13uM; PC3; HT_HG-U133A | NACA DOCK5 MICAL3 ASPSCR1 ARAP1 TAF1C DLGAP4 RABL6 MZF1 BRD4 SNAPC4 MAPK7 | 9.53e-08 | 195 | 190 | 12 | 2122_DN |
| Drug | Hyoscyamine (L) [101-31-5]; Down 200; 13.8uM; MCF7; HT_HG-U133A | BORCS6 CDKN1C TRADD SRCAP ADAM8 ABCA7 NFIB PXN BIN1 BICRA TNS2 | 6.74e-07 | 192 | 190 | 11 | 2271_DN |
| Drug | Mexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A | BORCS6 NAA80 SRCAP ADAM8 ABCA7 GGA3 PXN BIN1 DLGAP4 NUP214 THBS4 | 8.70e-07 | 197 | 190 | 11 | 2324_UP |
| Drug | nordihydroguaiaretic acid; Down 200; 1uM; MCF7; HT_HG-U133A | BORCS6 SRCAP ARHGEF11 ADAM8 ABCA7 NFKBIB ATN1 TNS2 CDC42EP1 BRD4 ZFHX2 | 9.14e-07 | 198 | 190 | 11 | 5583_DN |
| Drug | S(+)-Terguride [37686-84-3]; Down 200; 11.8uM; HL60; HT_HG-U133A | SETD1A SRCAP ABCA7 DOCK5 NFKBIB KMT2A UBR4 BAHD1 MZF1 TNK2 MAPK7 | 9.61e-07 | 199 | 190 | 11 | 3082_DN |
| Drug | beta- Belladonnine dichloroethylate [191355-47-2]; Down 200; 6uM; MCF7; HT_HG-U133A | BORCS6 RIN3 KAT2A SRCAP SYNJ1 NFKBIB ARAP1 TAF1C TNS2 POU2F2 INPP5J | 9.61e-07 | 199 | 190 | 11 | 2819_DN |
| Drug | 6,7-dimethoxy-2-(pyrrolidin-1-yl)-N-(5-(pyrrolidin-1-yl)pentyl)quinazolin-4-amine | 2.64e-06 | 104 | 190 | 8 | ctd:C000595015 | |
| Drug | Muramic acid, N-acetyl [10597-89-4]; Up 200; 13.6uM; MCF7; HT_HG-U133A | BORCS6 BCORL1 ARHGEF11 ATN1 TAF1C POU2F2 MMP25 COL18A1 MAPK7 MAST3 | 5.38e-06 | 193 | 190 | 10 | 3262_UP |
| Drug | Mefexamide hydrochloride [3413-64-7]; Down 200; 12.6uM; MCF7; HT_HG-U133A | BORCS6 SETD1A SRCAP ABCA7 PRDM2 PTPN12 NFKBIB BAHD1 TBC1D17 PPP2R3A | 5.64e-06 | 194 | 190 | 10 | 2284_DN |
| Drug | Ipratropium bromide [22254-24-6]; Up 200; 9.8uM; HL60; HG-U133A | TRADD RIN3 DYSF KMT2A DLGAP4 NUP214 ARHGEF15 SLC2A4RG YLPM1 MAST3 | 5.64e-06 | 194 | 190 | 10 | 1769_UP |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 1uM; MCF7; HT_HG-U133A | BORCS6 NAA80 SRCAP ARHGEF11 ADAM8 GGA3 NFKBIB A4GALT ATN1 TNS2 | 5.90e-06 | 195 | 190 | 10 | 3909_DN |
| Drug | Tiabendazole [148-79-8]; Up 200; 19.8uM; MCF7; HT_HG-U133A | EFS ADAM8 PPP1R37 UBR4 DOK2 ARHGEF40 CD8A TNK2 MYO15A INPP5J | 5.90e-06 | 195 | 190 | 10 | 4402_UP |
| Drug | Papaverine hydrochloride [61-25-6]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 5.90e-06 | 195 | 190 | 10 | 6245_UP | |
| Drug | Ursolic acid [77-52-1]; Down 200; 8.8uM; MCF7; HT_HG-U133A | ARHGEF11 NFIB NFKBIB ARAP1 BIN1 TNS2 NUP214 PPP2R3A LYL1 MAST3 | 6.17e-06 | 196 | 190 | 10 | 7181_DN |
| Drug | Naphazoline hydrochloride [550-99-2]; Up 200; 16.2uM; PC3; HG-U133A | MICAL3 BIN1 BICRA NUP214 CDC42EP1 RABL6 ARHGEF40 YLPM1 MAPK7 MAST3 | 6.17e-06 | 196 | 190 | 10 | 1886_UP |
| Drug | Norfloxacin [70458-96-7]; Down 200; 12.6uM; PC3; HT_HG-U133A | TRADD DOCK5 ASPSCR1 ARAP1 BIN1 BICRA DLGAP4 TNS2 MZF1 SNAPC4 | 6.17e-06 | 196 | 190 | 10 | 2090_DN |
| Drug | Methiazole; Down 200; 15uM; MCF7; HT_HG-U133A | SRCAP ADAM8 NFKBIB ATN1 CDC42EP1 NCOR2 PPP2R3A CD8A LYL1 MAST3 | 6.17e-06 | 196 | 190 | 10 | 3878_DN |
| Drug | Tetracycline hydrochloride [64-75-5]; Down 200; 8.4uM; PC3; HT_HG-U133A | 6.17e-06 | 196 | 190 | 10 | 5757_DN | |
| Drug | Pinacidil [85371-64-8]; Down 200; 16.4uM; HL60; HT_HG-U133A | 6.17e-06 | 196 | 190 | 10 | 2406_DN | |
| Drug | Ethambutol dihydrochloride [1070-11-7]; Up 200; 14.4uM; MCF7; HT_HG-U133A | SPEG BCL11A NFIB MICAL3 ARAP1 DLGAP4 POU2F2 ADAMTS12 NCOR2 ZFHX2 | 6.45e-06 | 197 | 190 | 10 | 4120_UP |
| Drug | Zidovudine, AZT [30516-87-1]; Down 200; 15uM; MCF7; HT_HG-U133A | CDKN1C ARHGEF11 MCM3AP A4GALT ANTXR1 MICAL3 ARAP1 BIN1 BICRA TNS2 | 6.45e-06 | 197 | 190 | 10 | 3211_DN |
| Drug | Metrizamide [31112-62-6]; Up 200; 5uM; MCF7; HT_HG-U133A | 6.45e-06 | 197 | 190 | 10 | 3255_UP | |
| Drug | Aminocaproic acid [60-32-2]; Down 200; 30.4uM; HL60; HT_HG-U133A | 6.45e-06 | 197 | 190 | 10 | 3122_DN | |
| Drug | Ramipril [87333-19-5]; Down 200; 9.6uM; MCF7; HT_HG-U133A | KAT2A SRCAP ARAP1 DLGAP4 NUP214 BAHD1 MZF1 PHACTR4 YLPM1 SNAPC4 | 6.45e-06 | 197 | 190 | 10 | 6792_DN |
| Drug | Tetracaone hydrochloride [136-47-0]; Up 200; 13.2uM; MCF7; HT_HG-U133A | CDKN1C SYNJ1 NFKBIB BIN1 AFF2 DLGAP4 NUP214 MZF1 MYO15A MAST3 | 6.75e-06 | 198 | 190 | 10 | 7473_UP |
| Drug | Roxarsone [121-19-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A | SRCAP ARHGEF11 ADAMTSL4 ARAP1 BIN1 TAF1C NUP214 PPP2R3A MZF1 DNAAF1 | 6.75e-06 | 198 | 190 | 10 | 5470_UP |
| Drug | Liothyronine [6893-02-3]; Up 200; 6.2uM; MCF7; HT_HG-U133A | BORCS6 BCL11A NRXN2 A4GALT ARAP1 AFF2 TNK2 MAPK7 INPP5J MAST3 | 6.75e-06 | 198 | 190 | 10 | 4947_UP |
| Drug | Diprophylline [479-18-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 6.75e-06 | 198 | 190 | 10 | 1689_UP | |
| Drug | Metampicillin sodium salt [6489-61-8]; Down 200; 10.4uM; MCF7; HT_HG-U133A | BORCS6 SRCAP ARHGEF11 ABCA7 NFKBIB A4GALT ATN1 DLGAP4 SORBS1 TBC1D17 | 6.75e-06 | 198 | 190 | 10 | 2286_DN |
| Drug | Asiaticoside [16830-15-2]; Down 200; 4.2uM; PC3; HT_HG-U133A | CDKN1C BCORL1 SRCAP PTPN12 NFRKB BIN1 EP400 TNS2 CDC42EP1 MZF1 | 6.75e-06 | 198 | 190 | 10 | 7244_DN |
| Drug | Antipyrine [60-80-0]; Down 200; 21.2uM; MCF7; HT_HG-U133A | SRCAP NFIB NFRKB PXN ARAP1 PRR36 CDC42EP1 MEGF9 INPP5J MAST3 | 7.06e-06 | 199 | 190 | 10 | 1489_DN |
| Drug | Rimexolone [49697-38-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 7.06e-06 | 199 | 190 | 10 | 3516_UP | |
| Drug | 5186324; Down 200; 2uM; MCF7; HT_HG-U133A_EA | NFIB NFKBIB A4GALT BIN1 PRR36 BICRA PPP2R3A TNK2 SNAPC4 MAPK7 | 7.06e-06 | 199 | 190 | 10 | 900_DN |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; HL60; HG-U133A | ARHGEF11 ADAM8 NFRKB KMT2A EP400 ADAMTS12 THBS4 MAP4K1 YLPM1 SNAPC4 | 7.06e-06 | 199 | 190 | 10 | 1768_UP |
| Drug | Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; PC3; HT_HG-U133A | 3.12e-05 | 189 | 190 | 9 | 4304_UP | |
| Drug | Fluocinonide [356-12-7]; Up 200; 8uM; PC3; HT_HG-U133A | 3.26e-05 | 190 | 190 | 9 | 4314_UP | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | 3.26e-05 | 190 | 190 | 9 | 4274_UP | |
| Drug | Flunisolide [3385-03-3]; Up 200; 9.2uM; PC3; HT_HG-U133A | 3.54e-05 | 192 | 190 | 9 | 4303_UP | |
| Drug | CP-690334-01 [459212-38-5]; Down 200; 10uM; MCF7; HT_HG-U133A | 3.68e-05 | 193 | 190 | 9 | 3906_DN | |
| Drug | Cyclacillin [3485-14-1]; Up 200; 11.8uM; PC3; HT_HG-U133A | 3.68e-05 | 193 | 190 | 9 | 4536_UP | |
| Drug | Cyclizine hydrochloride [303-25-3]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 3.83e-05 | 194 | 190 | 9 | 5525_UP | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; MCF7; HT_HG-U133A | 3.83e-05 | 194 | 190 | 9 | 5278_DN | |
| Drug | Spiramycin [8025-81-8]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 3.99e-05 | 195 | 190 | 9 | 3844_UP | |
| Drug | Clebopride maleate [84370-95-6]; Up 200; 8.2uM; HL60; HT_HG-U133A | SETD1A RPS6KB2 PDZD7 SRCAP ABCA7 NFKBIB ASPSCR1 DLGAP4 MAST3 | 3.99e-05 | 195 | 190 | 9 | 1292_UP |
| Drug | Dihydroergotamine tartrate [5989-77-5]; Down 200; 3uM; PC3; HT_HG-U133A | 3.99e-05 | 195 | 190 | 9 | 4502_DN | |
| Drug | 6-Hydroxytropinone [5932-53-6]; Down 200; 25.8uM; PC3; HT_HG-U133A | 3.99e-05 | 195 | 190 | 9 | 4250_DN | |
| Drug | 5213008; Down 200; 18uM; MCF7; HT_HG-U133A_EA | ARHGEF11 NPHP4 A4GALT PRR36 TNS2 BAHD1 CDC42EP1 BRD4 PHACTR4 | 3.99e-05 | 195 | 190 | 9 | 898_DN |
| Drug | genistein; Down 200; 1uM; MCF7; HG-U133A | 3.99e-05 | 195 | 190 | 9 | 268_DN | |
| Drug | Flumethasone [2135-17-3]; Up 200; 9.8uM; PC3; HT_HG-U133A | 3.99e-05 | 195 | 190 | 9 | 4272_UP | |
| Drug | Thiocolchicoside [602-41-5]; Up 200; 7uM; MCF7; HT_HG-U133A | 3.99e-05 | 195 | 190 | 9 | 2875_UP | |
| Drug | (-)-Quinpirole hydrochloride [85760-74-3]; Up 200; 15.6uM; MCF7; HT_HG-U133A | 4.15e-05 | 196 | 190 | 9 | 3539_UP | |
| Drug | Diprophylline [479-18-5]; Down 200; 15.8uM; PC3; HT_HG-U133A | 4.15e-05 | 196 | 190 | 9 | 5063_DN | |
| Drug | Ampyrone [83-07-8]; Up 200; 19.6uM; PC3; HT_HG-U133A | 4.15e-05 | 196 | 190 | 9 | 2086_UP | |
| Drug | Ethaverine hydrochloride [985-13-7]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 4.15e-05 | 196 | 190 | 9 | 3375_UP | |
| Drug | Tetrahydroalstonine [6474-90-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 4.15e-05 | 196 | 190 | 9 | 5728_DN | |
| Drug | Pyrimethamine [58-14-0]; Down 200; 16uM; MCF7; HT_HG-U133A | 4.15e-05 | 196 | 190 | 9 | 4779_DN | |
| Drug | Meglumine [6284-40-8]; Down 200; 20.4uM; MCF7; HT_HG-U133A | BCORL1 ARHGEF11 ADAM8 PRDM2 NFKBIB A4GALT ARAP1 ATN1 PPP2R3A | 4.15e-05 | 196 | 190 | 9 | 6445_DN |
| Drug | genistein; Up 200; 10uM; MCF7; HT_HG-U133A | 4.15e-05 | 196 | 190 | 9 | 5232_UP | |
| Drug | Nomegestrol acetate [58652-20-3]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 4.15e-05 | 196 | 190 | 9 | 5461_UP | |
| Drug | Pilocarpine nitrate [148-72-1]; Up 200; 14.8uM; MCF7; HT_HG-U133A | 4.15e-05 | 196 | 190 | 9 | 5341_UP | |
| Drug | F0447-0125; Down 200; 10uM; MCF7; HT_HG-U133A | 4.15e-05 | 196 | 190 | 9 | 6396_DN | |
| Drug | haloperidol; Down 200; 10uM; HL60; HT_HG-U133A | 4.15e-05 | 196 | 190 | 9 | 6203_DN | |
| Drug | Methamphetamine | SPEG OBSCN GIGYF1 KAT2A KMT2E DYSF PRDM2 PCGF6 TNRC6A PXN DLAT MLLT6 MICAL3 BIN1 EP400 TAF1C UBR4 TNS2 ICE1 TACC2 SORBS1 ARHGEF15 NCOR2 PPP2R3A ARAP3 KLF10 LRP1 | 4.19e-05 | 1401 | 190 | 27 | ctd:D008694 |
| Drug | alpha-estradiol; Down 200; 0.01uM; HL60; HT_HG-U133A | 4.32e-05 | 197 | 190 | 9 | 1151_DN | |
| Drug | Guaifenesin [93-14-1]; Up 200; 20.2uM; MCF7; HT_HG-U133A | BORCS6 SETD1A ARHGAP32 SRCAP ARHGEF11 ASPSCR1 TAF1C PPP2R3A MZF1 | 4.32e-05 | 197 | 190 | 9 | 3431_UP |
| Drug | Diprophylline [479-18-5]; Up 200; 15.8uM; MCF7; HT_HG-U133A | EFS ZC3H13 SRCAP ARHGEF11 ASPSCR1 POU2F2 PPP2R3A ARHGEF40 LYL1 | 4.32e-05 | 197 | 190 | 9 | 5482_UP |
| Drug | Phenelzine sulfate [156-51-4]; Down 200; 17uM; MCF7; HT_HG-U133A | 4.32e-05 | 197 | 190 | 9 | 3884_DN | |
| Drug | Metyrapone [54-36-4]; Down 200; 17.6uM; PC3; HT_HG-U133A | 4.32e-05 | 197 | 190 | 9 | 4606_DN | |
| Drug | Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 4.32e-05 | 197 | 190 | 9 | 2328_DN | |
| Drug | N6-methyladenosine [1867-73-8]; Down 200; 14.2uM; PC3; HT_HG-U133A | 4.32e-05 | 197 | 190 | 9 | 6732_DN | |
| Drug | PHA-00745360 [351320-33-7]; Up 200; 10uM; PC3; HT_HG-U133A | 4.32e-05 | 197 | 190 | 9 | 4559_UP | |
| Drug | Bethanechol chloride [590-63-6]; Down 200; 20.4uM; HL60; HT_HG-U133A | 4.32e-05 | 197 | 190 | 9 | 2975_DN | |
| Drug | Oxethazaine [126-27-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A | SETD1A ARHGAP32 KAT2A ARHGEF11 NFIB MICAL3 PPP2R3A PHACTR4 TNK2 | 4.32e-05 | 197 | 190 | 9 | 4829_DN |
| Drug | Calciferol [50-14-6]; Up 200; 10uM; MCF7; HT_HG-U133A | 4.32e-05 | 197 | 190 | 9 | 3304_UP | |
| Drug | Nadide [53-84-9]; Down 200; 6uM; MCF7; HT_HG-U133A | 4.32e-05 | 197 | 190 | 9 | 6091_DN | |
| Drug | Flecainide acetate [54143-56-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 4.32e-05 | 197 | 190 | 9 | 3937_DN | |
| Drug | Harmine hydrochloride [343-27-1]; Up 200; 16uM; HL60; HG-U133A | ARHGAP32 BCL11A NFRKB TAF1C DLGAP4 THBS4 SLC15A2 YLPM1 SNAPC4 | 4.32e-05 | 197 | 190 | 9 | 1758_UP |
| Drug | Benzonatate [104-31-4]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 4.32e-05 | 197 | 190 | 9 | 5435_UP | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Up 200; 6.2uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 2768_UP | |
| Drug | Metoclopramide monohydrochloride [7232-21-5]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 4750_DN | |
| Drug | Pentolinium bitartrate [52-62-0]; Up 200; 7.4uM; PC3; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 7375_UP | |
| Drug | Nitrendipine [39562-70-4]; Down 200; 11uM; HL60; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 3087_DN | |
| Drug | 16-phenyl tetranor Prostaglandin E2; Down 200; 10uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 7505_DN | |
| Drug | Diazoxide [364-98-7]; Down 200; 17.4uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 7168_DN | |
| Drug | Flutamide [13311-84-7]; Up 200; 14.4uM; PC3; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 3803_UP | |
| Drug | Cefuroxime sodium salt [56238-63-2]; Up 200; 9uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 6088_UP | |
| Drug | Megestrol acetate [595-33-5]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 5013_DN | |
| Drug | Thyroxine (L) [51-48-9]; Down 200; 5.2uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 4150_DN | |
| Drug | Trimetazidine dihydrochloride [13171-25-0]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 5479_UP | |
| Drug | Mesoridazine besylate [32672-69-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 7017_UP | |
| Drug | Rifampicin [13292-46-1]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 4126_UP | |
| Drug | Benfotiamine [22457-89-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 3931_UP | |
| Drug | Althiazide [5588-16-9]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 6089_DN | |
| Drug | minocycline; Down 200; 10.5uM; MCF7; HT_HG-U133A_EA | 4.49e-05 | 198 | 190 | 9 | 1135_DN | |
| Drug | Zoxazolamine [61-80-3]; Up 200; 23.8uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 5390_UP | |
| Drug | Sulfathiazole [72-14-0]; Up 200; 15.6uM; HL60; HG-U133A | 4.49e-05 | 198 | 190 | 9 | 1963_UP | |
| Drug | Ranitidine hydrochloride [66357-59-3]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 5425_UP | |
| Drug | Quinethazone [73-49-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 3793_DN | |
| Drug | Oxaprozin [21256-18-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 4.49e-05 | 198 | 190 | 9 | 3876_DN | |
| Disease | Intellectual Disability | SETD1A BCL11A KMT2E KMT2C NRXN2 NFIB CUX2 ATN1 CHAMP1 PDHX RABL6 COL18A1 SETD2 ZNF526 BRD4 | 1.56e-07 | 447 | 184 | 15 | C3714756 |
| Disease | testosterone measurement | TET2 BCORL1 SRCAP FOXA3 GGA3 DOCK5 GPR83 VARS1 BANK1 ARAP1 CASC3 CUX2 DLGAP4 FNBP4 AKNA CHAMP1 ARHGEF15 NCOR2 MLXIPL ARHGEF40 SLC2A4RG CD68 DAAM2 MYO15A | 1.47e-06 | 1275 | 184 | 24 | EFO_0004908 |
| Disease | Adenoid Cystic Carcinoma | 3.21e-06 | 100 | 184 | 7 | C0010606 | |
| Disease | household income | TET2 BCL11A KMT2E NFIB TNRC6A BSN ARAP1 CASC3 SGIP1 ARAP3 LYL1 | 3.62e-06 | 304 | 184 | 11 | EFO_0009695 |
| Disease | mean platelet volume | TET2 ARHGAP32 RIN3 SETD1B CDK12 NACA BCORL1 SRCAP DOCK5 A4GALT TNRC6A MAP3K11 BANK1 ARAP1 SORBS1 DOK2 MLXIPL SETD2 PROSER2 LYL1 | 6.50e-06 | 1020 | 184 | 20 | EFO_0004584 |
| Disease | cortical thickness | RIN3 DYSF FMNL2 PKD1 TNRC6A NAV1 KMT2A MICAL3 PLEKHA7 BANK1 WNK2 COL12A1 TLX3 TACC2 COL18A1 ARHGEF40 MEGF9 YLPM1 LRP1 CD68 | 2.29e-05 | 1113 | 184 | 20 | EFO_0004840 |
| Disease | alcohol consumption measurement | SETD1A KIRREL3-AS3 RAPH1 NPIPB9 CDK12 FMNL2 TNRC6A MICAL3 ASPSCR1 BANK1 CUX2 COL12A1 SGIP1 PCLO FNBP4 POU2F2 NCOR2 MLXIPL MEGF9 ABI2 MYO15A | 3.44e-05 | 1242 | 184 | 21 | EFO_0007878 |
| Disease | neurodevelopmental disorder with speech impairment and dysmorphic facies (implicated_via_orthology) | 3.87e-05 | 2 | 184 | 2 | DOID:0070417 (implicated_via_orthology) | |
| Disease | Kleefstra syndrome 2 (implicated_via_orthology) | 3.87e-05 | 2 | 184 | 2 | DOID:0080598 (implicated_via_orthology) | |
| Disease | cardiovascular disease biomarker measurement, internal carotid intimal medial thickness | 3.87e-05 | 2 | 184 | 2 | EFO_0005053, EFO_0005278 | |
| Disease | mean corpuscular hemoglobin concentration | SETD1B CDK12 RPS6KB2 GIGYF1 FOXA3 ABCA7 A4GALT ANTXR1 NEURL1B CUX2 ATN1 EP400 DLGAP4 ARHGEF15 MLXIPL ELL2 SLC2A4RG BRD4 MYO15A | 6.66e-05 | 1105 | 184 | 19 | EFO_0004528 |
| Disease | serine palmitoyltransferase 1 measurement | 1.16e-04 | 3 | 184 | 2 | EFO_0803055 | |
| Disease | free androgen index | 1.29e-04 | 374 | 184 | 10 | EFO_0007005 | |
| Disease | Malignant neoplasm of breast | TRERF1 RAPH1 RPS6KB2 BCORL1 OBSCN BCL11A DYSF GGA3 CLCN1 TREML1 UBR4 TACC2 SORBS1 NUP214 SETD2 KMT2D ARAP3 SPEN | 1.43e-04 | 1074 | 184 | 18 | C0006142 |
| Disease | alcohol drinking | 1.56e-04 | 81 | 184 | 5 | EFO_0004329 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.79e-04 | 45 | 184 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | Myopathy, Centronuclear, Autosomal Recessive | 2.30e-04 | 4 | 184 | 2 | C0410204 | |
| Disease | Alzheimer disease | ABI3 ABCA7 TNRC6A PPP1R37 ANTXR1 BANK1 BIN1 SRCIN1 SLC2A4RG MAPK7 MYO15A | 2.50e-04 | 485 | 184 | 11 | MONDO_0004975 |
| Disease | Neurodevelopmental Disorders | 2.98e-04 | 93 | 184 | 5 | C1535926 | |
| Disease | serum albumin measurement | RIN3 RAPH1 CDK12 KAT2A DYSF MICAL3 BSN BANK1 DOK2 MLXIPL ABI2 ZNF385C | 3.65e-04 | 592 | 184 | 12 | EFO_0004535 |
| Disease | Malignant Cystosarcoma Phyllodes | 3.82e-04 | 5 | 184 | 2 | C0600066 | |
| Disease | Pyruvate dehydrogenase complex deficiency | 3.82e-04 | 5 | 184 | 2 | cv:C0034345 | |
| Disease | Phyllodes Tumor | 3.82e-04 | 5 | 184 | 2 | C0010701 | |
| Disease | HbA1c measurement, polycystic ovary syndrome | 3.82e-04 | 5 | 184 | 2 | EFO_0000660, EFO_0004541 | |
| Disease | Usher Syndrome, Type II | 3.82e-04 | 5 | 184 | 2 | C1568249 | |
| Disease | attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement | TET2 KIRREL3-AS3 BCL11A PCGF6 NRXN2 TULP4 NFIB TNRC6A PCDH15 ASPSCR1 SGIP1 ZBTB9 TACC2 THBS4 | 5.31e-04 | 801 | 184 | 14 | EFO_0003888, EFO_0007052, MONDO_0002491 |
| Disease | pyruvate decarboxylase deficiency (is_implicated_in) | 5.71e-04 | 6 | 184 | 2 | DOID:3649 (is_implicated_in) | |
| Disease | C-reactive protein measurement | TRERF1 NFIB PKD1 PCDH15 PPP1R37 PXN MICAL3 NEURL1B BSN BANK1 ARAP1 BIN1 CUX2 SGIP1 ZBTB9 MLXIPL KLF10 SNAPC4 | 5.75e-04 | 1206 | 184 | 18 | EFO_0004458 |
| Disease | Sezary Syndrome | 6.25e-04 | 27 | 184 | 3 | C0036920 | |
| Disease | serum gamma-glutamyl transferase measurement | ARHGEF11 NFIB NFKBIB PKD1 KMT2A MICAL3 CUX2 SGIP1 BICRA PDHX ARHGEF15 NCOR2 MLXIPL SETD2 MAST3 | 6.45e-04 | 914 | 184 | 15 | EFO_0004532 |
| Disease | Leukemia, Myelocytic, Acute | 7.82e-04 | 173 | 184 | 6 | C0023467 | |
| Disease | Polycystic kidney disease, type 2 | 7.96e-04 | 7 | 184 | 2 | C2751306 | |
| Disease | congenital heart disease (implicated_via_orthology) | 9.22e-04 | 69 | 184 | 4 | DOID:1682 (implicated_via_orthology) | |
| Disease | attention deficit hyperactivity disorder, autism spectrum disorder, intelligence | 9.31e-04 | 398 | 184 | 9 | EFO_0003756, EFO_0003888, EFO_0004337 | |
| Disease | Ovarian Mucinous Adenocarcinoma | 9.43e-04 | 31 | 184 | 3 | C1335167 | |
| Disease | serum IgA measurement | 9.43e-04 | 31 | 184 | 3 | EFO_0004912 | |
| Disease | Alzheimer disease, educational attainment | 9.53e-04 | 247 | 184 | 7 | EFO_0011015, MONDO_0004975 | |
| Disease | Leigh syndrome | 1.06e-03 | 8 | 184 | 2 | cv:C0023264 | |
| Disease | Polycystic Kidney, Type 1 Autosomal Dominant Disease | 1.06e-03 | 8 | 184 | 2 | C0887850 | |
| Disease | Cornelia De Lange Syndrome | 1.06e-03 | 8 | 184 | 2 | C0270972 | |
| Disease | Lymphoid leukemia | 1.06e-03 | 8 | 184 | 2 | C0023448 | |
| Disease | serum alanine aminotransferase measurement | BCORL1 GPR83 NRXN2 WNK2 ARAP1 CUX2 COL12A1 PCLO FNBP4 AKNA MMP25 MLXIPL KLF10 MAST3 | 1.16e-03 | 869 | 184 | 14 | EFO_0004735 |
| Disease | pulse pressure measurement | TET2 RIN3 RAPH1 SRCAP DYSF RCOR2 PRR16 ASAP2 PKD1 TNRC6A NAV1 NEURL1B PLEKHA7 CUX2 SGIP1 DLGAP4 ABI2 PHACTR4 LRP1 | 1.17e-03 | 1392 | 184 | 19 | EFO_0005763 |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 40 | 1.35e-03 | 9 | 184 | 2 | C4225275 | |
| Disease | Polycystic Kidney, Autosomal Dominant | 1.35e-03 | 9 | 184 | 2 | C0085413 | |
| Disease | lactosyl-N-nervonoyl-sphingosine (d18:1/24:1) measurement | 1.35e-03 | 9 | 184 | 2 | EFO_0800517 | |
| Disease | idiopathic pulmonary fibrosis (is_implicated_in) | 1.35e-03 | 9 | 184 | 2 | DOID:0050156 (is_implicated_in) | |
| Disease | metabolic syndrome | 1.65e-03 | 200 | 184 | 6 | EFO_0000195 | |
| Disease | glucagon-like peptide-1 measurement | 1.68e-03 | 10 | 184 | 2 | EFO_0008465 | |
| Disease | stomach cancer (is_marker_for) | 2.01e-03 | 142 | 184 | 5 | DOID:10534 (is_marker_for) | |
| Disease | atrial fibrillation | 2.39e-03 | 371 | 184 | 8 | EFO_0000275 | |
| Disease | intracranial aneurysm (is_implicated_in) | 2.45e-03 | 12 | 184 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | immunoglobulin isotype switching measurement | 2.62e-03 | 44 | 184 | 3 | EFO_0010128 | |
| Disease | glucose measurement | 2.76e-03 | 380 | 184 | 8 | EFO_0004468 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 2.88e-03 | 13 | 184 | 2 | C1846647 | |
| Disease | prostate cancer (is_marker_for) | 3.02e-03 | 156 | 184 | 5 | DOID:10283 (is_marker_for) | |
| Disease | Salivary Gland Neoplasms | 3.16e-03 | 47 | 184 | 3 | C0036095 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 3.35e-03 | 14 | 184 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | revision of total hip arthroplasty | 3.35e-03 | 14 | 184 | 2 | EFO_0020973 | |
| Disease | mean arterial pressure, alcohol drinking | 3.35e-03 | 98 | 184 | 4 | EFO_0004329, EFO_0006340 | |
| Disease | dyslexia | 3.55e-03 | 162 | 184 | 5 | EFO_0005424 | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 3.56e-03 | 49 | 184 | 3 | DOID:0060037 (implicated_via_orthology) | |
| Disease | Schizophrenia | CDKN1C SETD1A ARHGAP32 BCL11A ARHGEF11 NRXN2 NAV1 KMT2A SHANK1 LMOD2 ADAMTS12 LRP1 DAAM2 | 3.75e-03 | 883 | 184 | 13 | C0036341 |
| Disease | Autosomal Recessive Centronuclear Myopathy | 3.85e-03 | 15 | 184 | 2 | C3645536 | |
| Disease | creatinine measurement | TET2 CDK12 SPEG OBSCN PPM1J PTPN12 NRXN2 MAP3K11 BSN PLEKHA7 CUX2 CDC42EP1 COL18A1 TNK2 | 3.98e-03 | 995 | 184 | 14 | EFO_0004518 |
| Disease | response to tenofovir | 3.99e-03 | 51 | 184 | 3 | EFO_0009279 | |
| Disease | peak expiratory flow | 4.21e-03 | 498 | 184 | 9 | EFO_0009718 | |
| Disease | nervousness | 4.38e-03 | 16 | 184 | 2 | NCIT_C74532 | |
| Disease | response to hydrochlorothiazide, systolic blood pressure change measurement | 4.38e-03 | 16 | 184 | 2 | EFO_0005202, EFO_0006944 | |
| Disease | mean reticulocyte volume | SETD1A RAPH1 BCL11A KAT2A ABCA7 ANTXR1 EP400 BAHD1 MLXIPL KLF10 BRD4 LYL1 | 4.53e-03 | 799 | 184 | 12 | EFO_0010701 |
| Disease | cortical surface area measurement | TET2 RIN3 RAPH1 EFS ZC3H13 DYSF FMNL2 PCGF6 ARHGAP31 NFIB PKD1 TNRC6A NAV1 PLEKHA7 BANK1 WNK2 TLX3 | 4.62e-03 | 1345 | 184 | 17 | EFO_0010736 |
| Disease | obsolete_red blood cell distribution width | SETD1B CDK12 RC3H1 BCL11A FOXA3 ABCA7 DOCK5 A4GALT NFRKB ANTXR1 NEURL1B EP400 MLXIPL BRD4 YLPM1 CD68 MAST3 | 4.69e-03 | 1347 | 184 | 17 | EFO_0005192 |
| Disease | vital capacity | TET2 RIN3 CDK12 KMT2E TULP4 ANTXR1 MICAL3 ASPSCR1 NEURL1B PCLO CHAMP1 NCOR2 SLC2A4RG BRD4 PROSER2 SNAPC4 | 4.76e-03 | 1236 | 184 | 16 | EFO_0004312 |
| Disease | lymphocyte count | TET2 RAPH1 GIGYF1 ARHGEF11 FMNL2 NUFIP1 PTPN12 NRXN2 ARHGAP31 MCM3AP MICAL3 NEURL1B VARS1 DOK2 ARHGEF15 SETD2 CD8A NEURL4 | 4.77e-03 | 1464 | 184 | 18 | EFO_0004587 |
| Disease | leukemia | 4.93e-03 | 55 | 184 | 3 | C0023418 | |
| Disease | Prostatic Neoplasms | 5.50e-03 | 616 | 184 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 5.50e-03 | 616 | 184 | 10 | C0376358 | |
| Disease | Dystonia, Paroxysmal | 5.54e-03 | 18 | 184 | 2 | C0393588 | |
| Disease | Myeloid Leukemia | 5.54e-03 | 18 | 184 | 2 | C0023470 | |
| Disease | Leukemia, Monocytic, Chronic | 5.54e-03 | 18 | 184 | 2 | C0023466 | |
| Disease | schizophrenia, inflammatory bowel disease | 5.54e-03 | 18 | 184 | 2 | EFO_0003767, MONDO_0005090 | |
| Disease | trait in response to apixaban | 5.91e-03 | 115 | 184 | 4 | OBA_2050328 | |
| Disease | reticulocyte count | BCL11A NUFIP1 DOCK5 A4GALT NFRKB PKD1 ANTXR1 BSN PLEKHA7 MLXIPL CD8A MEGF9 SLC45A1 ZNF385C | 6.07e-03 | 1045 | 184 | 14 | EFO_0007986 |
| Disease | neuroblastoma | 6.09e-03 | 116 | 184 | 4 | EFO_0000621 | |
| Disease | breast cancer (is_marker_for) | 6.20e-03 | 185 | 184 | 5 | DOID:1612 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LGPPLQPPPTPDPTC | 151 | Q66K41 | |
| PPAPTPRPTSIPPKE | 611 | Q8NDB2 | |
| LPVDPAPPCPRPLPT | 686 | Q96L91 | |
| PESPPSILTPPVVPT | 256 | P55198 | |
| PSPLPAPDPAPKSEP | 501 | Q9BZE9 | |
| TIASPPPPLPTTTPP | 531 | Q9NYV4 | |
| PPAAAAIPTPPPLPS | 366 | O00472 | |
| TITPPCPPEEPPPSR | 551 | Q8TER5 | |
| SRSPEPSPRPPPLPT | 126 | Q8WWN8 | |
| PSAPTPPIPSPPSTL | 526 | Q9H6X2 | |
| PLPPPPPAPVNTCPT | 411 | A6NF34 | |
| SPPPILENPTPEPPV | 601 | Q6UY14 | |
| PAEIPCPTLTPPTPP | 56 | Q9NPC4 | |
| PSVKVQSQPPPPLPP | 946 | O60885 | |
| PPPPPTPSSTTKLPQ | 366 | P10323 | |
| PPCISPAPPHKPPNT | 881 | P51816 | |
| DPPTEPPPLPPKSRG | 846 | Q12774 | |
| ELQVSSPPPPPPSSP | 6 | Q504U0 | |
| TPESPVPPARSPSPP | 736 | P54259 | |
| PAPSPPLAPVPALAP | 246 | Q5H9F3 | |
| APRITSVIPSPPPPP | 141 | O15085 | |
| SPVPPPKPSGSPCTP | 116 | O94989 | |
| KPTTTPAPRPPTPAP | 136 | P01732 | |
| KRPPPAPPVTVSSPP | 746 | P78325 | |
| PRSSPSPPPSPTEPE | 981 | O14529 | |
| PAPLPAPSPPPLCNL | 86 | Q8N5N4 | |
| TTELTAPPPPPAPPA | 261 | Q9Y2H0 | |
| PPTLKPVPPPTSRPR | 1016 | P58397 | |
| GPRPPKSPAPCPTPL | 776 | Q8IZY2 | |
| PLLLPPPSTPAPAAP | 891 | Q07912 | |
| LPRTTPPTQKPPSPP | 171 | Q9NYB9 | |
| SLPPPPLPPTSDPLE | 1196 | Q9HCE9 | |
| ISPPPFAPSPTLPPT | 771 | Q5TC82 | |
| STSVPRSVPPAPPPP | 426 | Q8IZ40 | |
| PPVPVPPPTLPKQQS | 831 | Q70E73 | |
| PESSLVFPPPPPSPV | 921 | Q70E73 | |
| STRTPPPPSPLPFPT | 356 | O00712 | |
| PPPSPLPFPTQAILP | 361 | O00712 | |
| SSVPPVPPSEALPPP | 331 | Q3YEC7 | |
| PTPTPAPSPASAPIP | 26 | Q92830 | |
| SAPIPTPTPAPAPAP | 36 | Q92830 | |
| PSVPSPLPKPPVPSA | 106 | Q8N7Y1 | |
| LLTPLPPSAPPSAPP | 346 | F8W0I5 | |
| PPLCTLPPGPEPPRF | 6 | Q9BUH6 | |
| PLPSSLDPPPPPAAV | 236 | Q9P2A4 | |
| EPPPPSPSPSPTSKE | 141 | P34810 | |
| PPAPPESTVRPAPPT | 171 | Q96SQ7 | |
| TTNDLPPPPPPLPFA | 536 | Q86T65 | |
| TRKPLAPPPQPPASP | 291 | Q9NPA2 | |
| LTLQPPPPVSEPAPP | 451 | Q13164 | |
| VPAPAPAPTPTPTPV | 586 | Q13164 | |
| APPSPSAPPPVVPKE | 811 | Q9Y618 | |
| DSLPPPSPTTPVPAP | 276 | O60496 | |
| PPVAASTPPPSPLPI | 1246 | Q7RTP6 | |
| VFVKPQAPPPPPAPS | 1846 | Q8NEZ4 | |
| QAVPVPPAPSSPPPL | 746 | O75420 | |
| TTPALPAIPISPPPV | 726 | Q6P4R8 | |
| LPPPPPLPECLTISP | 241 | Q93015 | |
| PQLPAETKPPTPAPP | 1021 | Q9UKN7 | |
| TCVPVPSPTPPPDAP | 4181 | Q07954 | |
| PLTPTPPPPVAKTPS | 841 | O43150 | |
| QSLPAPAPSPVPLPP | 1031 | O60318 | |
| PPDASLPPDPPPLTV | 156 | Q8N5H3 | |
| RSRPLSPVATPPPPP | 411 | Q6P5Q4 | |
| PPQPTKPSTAEPRPP | 306 | Q9UPA5 | |
| ATPPLPPLQSAPPPS | 356 | Q9H165 | |
| PPLQSAPPPSQPPVK | 361 | Q9H165 | |
| PPTPASKPLPDDPRP | 341 | Q15653 | |
| TRICTTAPPPVPPKP | 2476 | Q9Y6V0 | |
| TAPPPVPPKPSSIPS | 2481 | Q9Y6V0 | |
| VTDLKPQVPPPTPPP | 311 | P10515 | |
| PTPQPLAPTPSAPCP | 331 | P10515 | |
| PPVSKPSEPRPSPEP | 151 | O00330 | |
| ACTPPPQLPPVAPRP | 731 | Q9H5P4 | |
| KPRLPAPPPVTTPPL | 686 | P39060 | |
| APPLNSIPSVTPPPP | 426 | P09086 | |
| PPTPPASPPPSVLIS | 71 | Q8IZD2 | |
| LPTPPATEAPSSPPP | 186 | Q9H1U4 | |
| PPSAPPPTTAATPLP | 1451 | P35658 | |
| PPPPLATPAPLTVIP | 76 | Q99583 | |
| IPVVTNSPQPLPPPP | 91 | Q99583 | |
| STLPPPSTTPAPLPP | 366 | Q99583 | |
| LPPPFPAPVVPASVP | 461 | Q9NZ52 | |
| PSSPVPTPPPDASPI | 411 | Q96N21 | |
| PLAPLPPSPLPPSVD | 286 | O75200 | |
| TLPPALPPPESPPKV | 981 | Q8IZL8 | |
| SVPVSSVSLIPPPPP | 1021 | A7KAX9 | |
| PPKPQEDRPPSPVPS | 366 | Q9NYM4 | |
| TPLPPPATSPSSPRP | 676 | Q06190 | |
| IPPEPPRTPPFPAKT | 351 | Q8IZ21 | |
| PSRKPPTSPSSPPAP | 471 | O75161 | |
| SPPERAEPPASPTPP | 576 | O75864 | |
| LAEPPKPVPPQPSAP | 4616 | Q5VST9 | |
| QEIAVPPPVPPPPSS | 41 | P49023 | |
| DPPPVATRSPFVPPP | 386 | P58401 | |
| LFCPPPSPPSIPLPL | 1776 | Q96QU1 | |
| PPLLSPVPSPPPMSS | 341 | Q9Y2F5 | |
| PCPAPAPTPTPAIPP | 241 | Q96GS4 | |
| LIPAPPVPETTPTPP | 431 | O15234 | |
| SPPQSTPLSPPPLTP | 1781 | Q9H7D0 | |
| EAPTEPPTPPPPPTI | 2296 | Q99715 | |
| LPSVPVPAPASTPPP | 136 | P49918 | |
| STPPPVPVLAPAPAP | 146 | P49918 | |
| PVPSPEPQKPAPVSP | 201 | Q96JM3 | |
| SPPAPSPAPPAISPI | 101 | Q00587 | |
| SSPKPLVPRPGPAPP | 66 | A6NJJ6 | |
| ELPPDLPKPPSPAPS | 91 | Q8TBE0 | |
| PLPNKTISPPPAPAP | 1036 | Q7Z591 | |
| PLPALPVPEAPSPSP | 306 | O43281 | |
| PVPEAPSPSPVPSPA | 311 | O43281 | |
| TVPAPPLAPPLPSAP | 581 | Q96PY5 | |
| VCAPSPAPAPPPKPA | 21 | P12980 | |
| PSPLACPPISAPPPR | 1186 | O60307 | |
| CPPISAPPPRSPSPL | 1191 | O60307 | |
| TLPAEAPPPPPPVEV | 441 | Q8NEP3 | |
| PSTPPSQPPAVCPPV | 291 | Q13118 | |
| QTSSSPPPPLLTPPP | 556 | Q03164 | |
| PPQPPTTGPPRKEVP | 1306 | Q03164 | |
| PQASSIPSPPLPPSP | 21 | Q5BKX5 | |
| APVPVPLPPSTPAPV | 631 | Q12929 | |
| TPPSPTPANPEPTLP | 41 | Q7Z7M8 | |
| SPSQLRKGPPVPPPP | 331 | O00499 | |
| PPATLKVAEPPPRPP | 1336 | Q9NZM4 | |
| PVSIEEVPPRPPSPP | 16 | Q16348 | |
| RPSPPPPPNTPCPLE | 91 | Q9Y2W3 | |
| PLFPPPTPLEPSPTL | 131 | O75923 | |
| PPPPPPQVTSAIATL | 716 | Q9UL51 | |
| PESPAPPSRPLPPQT | 286 | Q3KP66 | |
| TTPPTPTPAPCPTEP | 676 | Q16584 | |
| PTPAPCPTEPPPSPL | 681 | Q16584 | |
| PLAPLPPSPLPPSVD | 301 | F8W1W9 | |
| FSPPTPIPTPPLEPL | 211 | Q96JN8 | |
| LPPLLIPTDPSSPPP | 961 | Q13029 | |
| IPTDPSSPPPCPPVL | 966 | Q13029 | |
| CPPVLTVATPPPPLL | 976 | Q13029 | |
| PPPLLPTVPLPAPSS | 986 | Q13029 | |
| TVSPSPSPIPPVEPL | 1026 | Q13029 | |
| PPPPPAPTCRGPTLL | 251 | P98161 | |
| LLTPLPPSAPPSAPP | 346 | A6NJU9 | |
| AALPPPPPVSPPALT | 21 | Q9BYE7 | |
| APACPLPTSPPVPAP | 306 | Q8TB24 | |
| IPTPAEDTPPPLPPK | 386 | Q92918 | |
| STPVPTPPAPPAAPT | 901 | Q8NEY1 | |
| PPPTLPPPSLAAPLS | 51 | Q8N461 | |
| RPPPPPTKPPETEAQ | 281 | Q9UJJ7 | |
| CLQPPPTSRTPFPPP | 41 | P26640 | |
| QPPVPSLSEVKPPPP | 181 | Q15628 | |
| SLSEVKPPPPPPPAQ | 186 | Q15628 | |
| PPVPLLPPGTSPPVD | 1541 | O43426 | |
| ASAPPPTPPRPEPKE | 166 | Q8N3X1 | |
| AVPTATIIEPPPPPP | 896 | Q8N3X1 | |
| LPPPPPSTTAPLPIR | 451 | Q9UBS0 | |
| TPPPPDPPAPETLLA | 146 | Q86WR7 | |
| PPADALPLPPTTPPS | 781 | Q15572 | |
| TVTSPPQPPPPAPEP | 246 | P55318 | |
| NPPPPPPRLTPVKCE | 121 | Q569H4 | |
| PPIRPATVPPPTAPK | 276 | Q569H4 | |
| LPSPPATPPSQVPPT | 386 | Q9H6K5 | |
| PPPETPSSIATPPPQ | 801 | Q9H6K5 | |
| PVPPILTPSPPSAFP | 361 | Q05209 | |
| KPPPQPSPPTSPVRT | 861 | Q6IQ23 | |
| PSPPPLCLPTTPGTP | 191 | Q5JR12 | |
| PIIPPPPPICPDSLD | 241 | Q16637 | |
| APSVLAPTLPLPPPP | 671 | Q9UPS6 | |
| NLPVVAPPVPCAPPP | 211 | A6NGB9 | |
| PPTPPPLPPASVLSD | 231 | A6NGB9 | |
| KSSEELSLPPPPPPP | 631 | Q8TF30 | |
| PVPTPVPVRNPTPVP | 96 | P59797 | |
| LTPVPPLAPAPRPPS | 1321 | Q6ZRS2 | |
| ILPSPPPPSQIPPCS | 2481 | Q6ZRS2 | |
| CTFLPPTPAPTPPRP | 566 | Q9NP71 | |
| VPAPEPPPATPPQAK | 1176 | O15047 | |
| VKPTPPAPALRPPEP | 1306 | O15047 | |
| PLPDTPAPATPLPPV | 1591 | Q9Y566 | |
| SPPVPATPPEPLPTT | 91 | Q96P48 | |
| SPETPVPSPSPEPPL | 926 | P35523 | |
| APSGQTVPPPLPKPP | 331 | Q15735 | |
| TVPPPLPKPPRSPSR | 336 | Q15735 | |
| LPQIPTPTLPPPPSE | 431 | Q8ND24 | |
| PSTVVPPAPPAPPTR | 271 | P35443 | |
| IPAAPTTAAPPPPLP | 841 | Q9NRJ4 | |
| PLSPTRAPPTPPPST | 611 | Q9HA65 | |
| LPVSSPEPPPALPPA | 391 | Q9BYV6 | |
| SAPTPLPTPVPPPLA | 131 | Q96K62 | |
| VLSLPAATPPPPPQP | 1386 | Q9C0A1 | |
| TPTKASVPPDLPPPP | 2421 | Q96T58 | |
| AAPTPTPAPVPVPVP | 3241 | Q96T58 | |
| TPAPVPVPVPLPAPA | 3246 | Q96T58 | |
| AMLPPPPPPLTSSLP | 41 | Q9UHK0 | |
| PPPSKSALLPPPSPR | 301 | Q15772 | |
| RTEKPSKSPPPPPPR | 996 | Q9C0H9 | |
| PPLPPPPVLSTVANP | 296 | Q9NR83 | |
| GTPPPLPPKNVPATP | 246 | Q9BQI5 | |
| PPAPEVLASAPPLPP | 311 | Q6VEQ5 | |
| FSPPPPLVPPAPEDL | 241 | Q9BX66 | |
| PPPPLPPPVSQVDAA | 101 | Q9NVV9 | |
| PPAPEVLASAPPLPP | 311 | A8K0Z3 | |
| PLSPPVSPVFSPPEP | 481 | A8MQ27 | |
| PLVTPPQSPVSPQPP | 271 | Q2TAL5 | |
| PESTTPVKAPPAPPP | 1956 | O95359 | |
| LPPAPPPPTPLEEST | 781 | Q2M1Z3 | |
| PPPPPPAQATTLSSP | 191 | Q9BYW2 | |
| PPPLPSALPAMPSVP | 101 | O43711 | |
| PPPVLPPPSLSSTAP | 601 | P49750 | |
| PPPSLSSTAPPPVMP | 606 | P49750 | |
| PPVMPLPPLSSATPP | 616 | P49750 | |
| PLPPVPASPTCNPAP | 6 | Q96C00 | |
| PPAPTATVPAPQPPV | 236 | O43670 | |
| LTLQPPRSPSPAPPP | 601 | Q8TF50 | |
| PPFLPAAPSPTPLPV | 1041 | Q5SXM2 | |
| LPTPPAPPDPFKSPA | 601 | Q6NUN9 | |
| SAPREPLPPPAPEPS | 1506 | Q9Y3S1 | |
| KPSLPAPSSLPPLPP | 256 | Q86YW5 | |
| PPPPPPLESSPRVKS | 611 | Q5T4S7 | |
| TTPPPPSQLLLSPPP | 396 | Q6N021 | |
| LITPPPPPPSPERVG | 31 | Q96HE9 | |
| PPPPAPEVLASAPPL | 291 | Q9NQA3 | |
| TPVPELPGPLSTPVP | 411 | P18583 | |
| PLPPKNITAPSRPPP | 1721 | Q8NDV7 | |
| PEPLAPSPVSPTFPP | 966 | Q63HR2 | |
| PRTPSPPPPIPEDIA | 261 | Q5T200 | |
| PPPPPQLPPEAESLT | 566 | Q96PN7 | |
| SPPSPALETPLSPPP | 526 | O14686 | |
| SPLSPPPEESPLSPP | 606 | O14686 | |
| PLSPPPEASRLSPPP | 616 | O14686 | |
| RLSPPPEESPLSPPP | 661 | O14686 | |
| LSPPPEESPTSPPPE | 671 | O14686 | |
| PPDPLPPPLSPIITA | 931 | O14686 | |
| PPLTPRPQPPPPESC | 2381 | O14686 | |
| TPPPKGAPTPPAVTP | 1326 | E9PAV3 | |
| PETEPPTPEPGPKTP | 156 | P28698 |